InvestorBrandNetwork (IBN) Content Platform

August 12, 2024 08:14:37

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is planning to consolidate its issued and outstanding class A multiple voting shares and class B subordinate voting shares. The company also has announced a planned name change to Quantum BioPharma Ltd, with a new trading symbol of QNTM. The consolidation, which is part of the company’s efforts to regain compliance with NASDAQ’s minimum bid price, and name change are subject to approval by the NASDAQ exchange; if approved, the changes will be effective Aug. 15, 2024. These actions have all been approved by company shareholders at the annual general and special meeting of shareholders held on July 22, 2024.

The company also announced a nonbrokered private placement of post-consolidation Class A multiple voting shares. “The company expects to offer up to four Class A multiple voting shares at a price of $18 per Class A multiple voting share, and expects that the entirety of the offering will be subscribed for by entities beneficially owned or controlled by Zeeshan Saeed and Anthony Durkacz, being the existing holders of Class A multiple voting shares,” the company said in the press release.

To view the full press release, visit https://ibn.fm/oEK6C

About FSD Pharma Inc.

FSD is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (“Lucid”), FSD is focused on the research and development of its lead compound, Lucid-MS (formerly Lucid-21-302) (“Lucid-MS”). Lucid-MS is a patented new chemical entity shown in preclinical models to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. FSD Pharma invented unbuzzd(TM) and spun out its over-the-counter (“OTC”) version to a company, Celly Nutrition, led by industry veterans. FSD retains ownership of 25.71% of Celly Nutrition Corp. The agreement with Celly Nutrition also includes royalty payments of 7% of sales from unbuzzd until payments to FSD Pharma total $250 million. Once $250 million is reached, the royalty drops to 3% in perpetuity. Additionally, FSD Pharma retains a large tax-loss carry forward of approximately C$130 million and could be utilized in the future to offset tax-payable obligations against future profits. FSD Pharma retains 100% of the rights to develop similar product or alternative formulations specifically for pharmaceutical/medical uses. FSD Pharma maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represent loans secured by residential or commercial property. For more information about the company, please visit www.FSDPharma.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Annovis Bio Inc. (NYSE: ANVS) Secures U.S. Patent Covering Methods For Treating TBI and Preventing Nerve Cell Death With Buntanetap

August 12, 2024 08:05:00

U.S. Patent No. 12,042,482 specifically addresses traumatic brain injury (“TBI”) treatment with buntanetap, enhancing Annovis Bio’s portfolio that includes various patents and applications for using buntanetap in treating both acute and chronic neurodegenerative diseases and mental illnesses
Buntanetap targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins such as amyloid beta, tau, alpha-synuclein, and TDP43
TBI is one of the major causes of death and disability in the US with annual death rate exceeding 70,000

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company, announced the issuance of a U.S. patent for treating traumatic brain injury (“TBI”) with its lead drug candidate, buntanetap. Initially filed in 2016, the patent covered treatments for various nerve injuries, including TBI, stroke, and spinal cord injuries, but required division into individual patents by the USPTO. Now, U.S. Patent No. 12,042,482, which specifically addresses the treatment of TBI and nerve injury with buntanetap, is successfully added in Annovis Bio’s diverse portfolio covering treatments for multiple acute and chronic neurodegenerative diseases and mental illnesses (https://ibn.fm/tU6FR).

Buntanetap (formerly Posiphen) targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins such as amyloid beta, tau, alpha-synuclein, and TDP43; by inhibiting their translation the drug improves synaptic transmission, axonal transport, reduces neuroinflammation, and protects…

NOTE TO INVESTORS: The latest news and updates relating to ANVS are available in the company’s newsroom at https://ibn.fm/ANVS

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

Why BTC, the Crypto Market Is Experiencing a Major Crash

August 12, 2024 08:05:00

Bitcoin suffered one of its most significant declines this week, dropping nearly 20% in value and hitting its lowest point in half a year. Other major cryptocurrencies faced even steeper losses, with most of them decreasing by more than 20% since Sunday. Collectively, these losses have wiped out more than $300 billion from the cryptocurrency market, sparking investor concerns that the bull market might be ending.

The recent downturn in the crypto market can be linked to wider economic instability, which caused significant drops in stock markets around Asia and Europe on Monday. The cryptocurrency market frequently falters along with traditional financial markets as investors try to sell off riskier and more…

About CryptoCurrencyWire

CryptoCurrencyWire (“CCW”) is a specialized communications platform with a focus on blockchain and the cryptocurrency sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CCW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CCW brings its clients unparalleled recognition and brand awareness. CCW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CryptoCurrencyWire, text “CRYPTO” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CryptoCurrencyWire.com

Please see full terms of use and disclaimers on the CryptoCurrencyWire website applicable to all content provided by CCW, wherever published or re-published: https://www.CryptoCurrencyWire.com/Disclaimer

CryptoCurrencyWire
New York, NY
www.CryptoCurrencyWire.com
212.994.9818 Office
[email protected]

CryptoCurrencyWire is powered by IBN

Next-Gen Renewable Energy Technology Summit to Be Held in New York

August 12, 2024 08:05:00

Experts in the renewable-energy space are set to congregate in New York to discuss how next-generation green-energy strategies and technologies can accelerate the deployment of renewable energy infrastructure and simultaneously support economic development in New York State. The Future Energy Economy Summit will run from Sept. 4–5, 2024, and bring together power producers, federal leaders, business groups, environmental groups, relevant state authorities and agencies, as well as other relevant stakeholders.

Attendees at the summit will discuss how next-gen renewable technologies could aid in the deployment and expansion of industrial and commercial enterprises. Furthermore, participants will explore how these technologies can speed up the installation of the dispatchable zero-emission resources required to…

NOTE TO INVESTORS: The latest news and updates relating to Mullen Automotive Inc. (NASDAQ: MULN) are available in the company’s newsroom at https://ibn.fm/MULN

About GreenEnergyStocks

GreenEnergyStocks (“GES”) is a specialized communications platform with a focus on companies working to shape the future of the green economy. GreenEnergyStocks is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, GES is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, GES brings its clients unparalleled recognition and brand awareness. GES is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from GreenEnergyStocks, text “Green” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenEnergyStocks.com

Please see full terms of use and disclaimers on the GreenEnergyStocks website applicable to all content provided by GES, wherever published or re-published: https://www.greennrgstocks.com/Disclaimer

GreenEnergyStocks
Los Angeles, CA
www.GreenEnergyStocks.com
310.299.1717 Office
[email protected]

GreenEnergyStocks is powered by IBN

Lucid Motors Secures Funding to Keep Afloat Through 2025

August 12, 2024 08:05:00

Lucid Motors (NASDAQ: LCID) has secured $1.5 billion to boost its operations and expansion plans to keep it afloat until the fourth quarter of 2025. The substantial funding, which came from Saudi Arabia’s Public Investment Fund (PIF), is pivotal for Lucid’s future.

Lucid Group recently announced that this funding would ramp up the production of a new SUV, which will, in turn, significantly improve the company’s growth trajectory. The news comes at a critical time when emerging EV makers are trying to compete with giants such as Tesla amid the challenges faced in…

About BillionDollarClub

BillionDollarClub (“BDC”) is a specialized communications platform with a focus on the biggest and brightest companies covered by IBN. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BDC is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, BDC brings its clients unparalleled recognition and brand awareness.

BDC is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BillionDollarClub, text “Billion” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BillionDollarClub.com

Please see full terms of use and disclaimers on the BillionDollarClub website applicable to all content provided by BDC, wherever published or re-published: https://www.BillionDollarClub.com/Disclaimer

BillionDollarClub
Los Angeles, CA
www.BillionDollarClub.com
310.299.1717 Office
[email protected]

BillionDollarClub is powered by IBN

Massachusetts Lawmakers Forward Bill Creating Psychedelics Working Group to Governor’s Desk

August 9, 2024 22:05:00

Legislators in the state of Massachusetts have forwarded a measure focused on military veterans to the governor’s desk for approval. The measure includes provisions to establish a psychedelic working group to conduct research and give recommendations on the potential therapeutic benefits of psychedelics like MDMA and psilocybin.

In particular, the group would explore whether psychedelic therapy was linked to improved outcomes among veterans diagnosed with a range of…

About PsychedelicNewsWire

PsychedelicNewsWire (“PNW”) is a specialized communications platform with a focus on all aspects of psychedelics and the latest developments and advances in the psychedelics sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, PNW brings its clients unparalleled recognition and brand awareness. PNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from PsychedelicNewsWire, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

PsychedelicNewsWire
San Francisco, CA
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]

PsychedelicNewsWire is powered by IBN

420 with CNW — Chinese Money Launderers Taking Over Marijuana Trafficking in US

August 9, 2024 15:25:00

For decades, Chinese criminal organizations have covertly operated in major U.S. cities such as New York and San Francisco. Their activities, which include cybercrime and wildlife trafficking, have largely flown by without law enforcement noticing due to their nonviolent nature.

Historically, these groups have remained more active and visible in the Pacific and Asia, especially in nations such as Singapore and Australia, where they have…

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

ChineseNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Releases Q2 2024 Financial

August 9, 2024 13:57:00

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, is reporting its financial results and company update for the second quarter of 2024. Highlights of the report include a collaboration agreement with Korean Tier-One KONEC, a contract to supply advanced systems for SUNWAY-AI autonomous logistics vehicles, and a follow-up order from a leading Japanese manufacturer, to name a few.

The report also showed that the company reported a U.S. generally accepted accounting principles (“GAAP”) operating loss of $3,200,000 for the quarter, a 25.6% decrease from the same quarter in 2023. In addition, Foresight saw a GAAP net loss of $3,200,000 and a non-GAAP net loss of $3,000,000 for the quarter, compared to a non-GAAP loss of $5,700,000 for the same period in 2023. The report noted that the financial results reflect the company’s efficiency that has been achieved primarily through a renewed focus on enhancing client-facing initiatives and the strategic reallocation of resources.

“Foresight’s innovative technologies continue to gain momentum in the automotive and defense industries, particularly in Europe and Asia,” said Foresight CEO Haim Siboni in the press release. “In the second quarter, we also had exciting updates regarding Eye-Net, Foresight’s wholly owned subsidiary. Eye-Net will work together with insurance and technology companies in Japan to assess the integration benefits of Eye-Net’s solutions in the technology company’s dashboard cameras. This proof of concept project follows Eye-Net’s progress in Japan based on the company’s relationship with SoftBank. We expect to see new commercial opportunities for both Eye-Net and Foresight during the second half of 2024.”

To view the full press release, visit https://ibn.fm/TMR6l

About Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings is a technology company developing smart multispectral vision software solutions and cellular-based applications. Through the company’s wholly owned subsidiaries — Foresight Automotive Ltd., Foresight Changzhou Automotive Ltd. and Eye-Net Mobile Ltd. — Foresight develops both “in-line-of-sight” vision systems and “beyond-line-of-sight” accident-prevention solutions. Foresight vision solutions include modules of automatic calibration and dense three-dimensional (“3D”) point cloud that can be applied to different markets such as automotive, defense, autonomous vehicles and heavy industrial equipment. Eye-Net Mobile’s cellular-based solution suite provides real-time, precollision alerts to enhance road safety and situational awareness for all road users in the urban mobility environment by incorporating cutting-edge AI technology and advanced analytics. For more information, visit the company’s website at www.ForesightAuto.com.

NOTE TO INVESTORS: The latest news and updates relating to FRSX are available in the company’s newsroom at http://ibn.fm/FRSX

About ChineseWire

ChineseWire (“CW”) is a specialized communications platform with a focus on promising China-based companies that are listed in North America. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CW brings its clients unparalleled recognition and brand awareness. CW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.ChineseWire.com

Please see full terms of use and disclaimers on the ChineseWire website applicable to all content provided by CW, wherever published or re-published: https://www.ChineseWire.com/Disclaimer

ChineseWire
Los Angeles, CA
www.ChineseWire.com
310.299.1717 Office
[email protected]

ChineseWire is powered by IBN

TechMediaBreaks – Aditxt Inc. (NASDAQ: ADTX) Enters into $1.2M Registered Direct Offering Agreement

August 9, 2024 13:51:57

Aditxt (NASDAQ: ADTX), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, has entered into a securities purchase agreement with certain institutional investors. The agreement outlines a registered direct offering for the purchase and sale of 1,130,189 shares of common stock or common stock equivalents for $1.06 per share. Proceeds from the offering are projected to total approximately $1.2 million before standard deductions, and the company plans to use the funds for obligations under its Amended and Restated Merger Agreement with Evofem Biosciences Inc. as well as for working capital and other general corporate purposes. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

To view the full press release, visit https://ibn.fm/v5GiI

About Aditxt Inc.

Aditxt is an innovation platform dedicated to discovering, developing and deploying promising innovations. Aditxt’s ecosystem of research institutions, industry partners and shareholders collaboratively drive its mission to “Make Promising Innovations Possible Together.” The innovation platform is the cornerstone of Aditxt’s strategy, where multiple disciplines drive disruptive growth and address significant societal challenges. Aditxt operates a unique model that democratizes innovation, ensures every stakeholder’s voice is heard and valued, and empowers collective progress. Aditxt has a diverse innovation portfolio, including Adimune(TM) Inc., which is leading the charge in developing a novel class of therapeutics for retraining the immune system to combat organ rejection, autoimmunity and allergies. Adivir(TM) Inc. focuses on enhancing national and population health and impacting public health globally. Pearsanta(TM) Inc. delivers rapid, personalized and high-quality lab testing accessible anytime, anywhere, led by its CLIA-certified and CAP-accredited clinical laboratory based in Richmond, Virginia. For more information, please visit www.Aditxt.com.

NOTE TO INVESTORS: The latest news and updates relating to ADTX are available in the company’s newsroom at https://ibn.fm/ADTX

About TechMediaWire

TechMediaWire (“TMW”) is a specialized communications platform with a focus on pioneering public and private companies driving the future of technology. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, TMW brings its clients unparalleled recognition and brand awareness. TMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
[email protected]

TechMediaWire is powered by IBN

MiningNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) Appoints Seasoned Professional as New CFO

August 9, 2024 13:48:15

Uranium Energy (NYSE American: UEC), a U.S.-based uranium mining and exploration company, has named a new chief financial officer. According to the announcement, veteran Josephine Man has joined Uranium Energy as CFO and treasurer, succeeding Pat Obara, who will be serving as senior vice president, administration. The changes will be effective Oct. 1, 2024. Man brings almost three decades of experience as a financial professional; she currently serves as CFO of Uranium Royalty Corp. (NASDAQ: UROY) (TSX: URC).

“On behalf of the board of directors and the entire Uranium Energy team, I would like to thank Pat for his leadership that has helped build Uranium Energy to where it is today,” said Uranium Energy CEO and president Amir Adnani in the press release. “We look forward to working with Josephine as she transitions into her role at the company. Her strong financial background and experience will be invaluable as we seek to ramp up our operations and move into commercial production.”

To view the full press release, visit https://ibn.fm/6IIbf

About Uranium Energy Corp.

Uranium Energy Corp is the fastest-growing supplier of the fuel for green-energy transition to a low-carbon future. UEC is the largest diversified North American-focused uranium company, advancing the next generation of low-cost, environmentally friendly, in-situ recovery (“ISR”) uranium projects in the United States and high-grade conventional projects in Canada. The company has two production-ready, ISR hub-and-spoke platforms in south Texas and Wyoming. These two production platforms are anchored by fully operational central processing plants and served by seven U.S. ISR uranium projects with all their major permits in place. Additionally, UEC has diversified uranium holdings including: (1) one of the largest physical uranium portfolios of North American-warehoused U3O8; (2) a major equity stake in Uranium Royalty Corp., the only royalty company in the sector; and (3) a Western Hemisphere pipeline of resource-stage uranium projects. The company’s operations are managed by professionals with decades of hands-on experience in the key facets of uranium exploration, development and mining. For more information about the company, visit www.UraniumEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC

About MiningNewsWire

MiningNewsWire (“MNW”) is a specialized communications platform with a focus on developments and opportunities in the Global Mining and Resources sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled recognition and brand awareness.

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Releases Q1 2025 Financial, Operational Results Report

August 9, 2024 13:43:38

IGC Pharma (NYSE American: IGC), a clinical-stage pharmaceutical company, is reporting on the results for its first fiscal quarter of 2025, the period ended on June 30, 2024. According to the report, highlights for the company included the company’s collaboration with Pablo Arbelaez, a renowned AI expert and researcher, in the development of the phase 2 clinical trial of IGC-AD1, the lead therapeutic candidate addressing agitation in Alzheimer’s disease. The company also announced that interim data from its phase 2 clinical trial indicates a reduction in agitation in Alzheimer’s, that patient enrollment has begun for its ongoing phase 2 clinical trial investigating IGC-AD1, and that it has extended its Master Loan and Security Agreement by one year.

“The first quarter of fiscal 2025 was marked by significant milestones in our Alzheimer’s research portfolio, underscoring our strategic focus on our innovations,” said IGC Pharma CEO Ram Mukunda in the press release. “The progress in our phase 2 clinical trial for IGC-AD1, highlighted by interim data demonstrating a clinically significant reduction in agitation, validates the immense potential of our lead investigational drug. Additionally, the positive preclinical outcomes for TGR-63 underscore its promise as a transformative therapy for Alzheimer’s, advancing us closer to delivering a novel solution for this critical unmet need. We are strategically positioned to continue expanding our clinical trial footprint and patient enrollment throughout fiscal 2025 as we continue to drive toward commercialization while maximizing operational efficiency and leveraging our unique vertically integrated model.”

To view the full press release, visit https://ibn.fm/vvb1g

About IGC Pharma

IGC Pharma is an artificial intelligence (“AI”)-powered, clinical-stage biotechnology company focused on developing innovative treatments for Alzheimer’s disease with the mission to transform patient care with fast-acting, safe and effective solutions. The company’s portfolio includes the TGR family, including TGR-63, which targets amyloid plaques, a hallmark of Alzheimer’s. The IGC-C and IGC-M platforms are advancing in preclinical stages, focusing on tau proteins, early plaque formation and multiple disease hallmarks. IGC Pharma’s lead therapeutic candidate, IGC-AD1, is a cannabinoid-based treatment currently in a phase 2 trial for agitation in dementia associated with Alzheimer’s. Interim data for IGC-AD1 demonstrated that it has the potential to transform patient care by offering faster-acting and more effective relief compared to traditional medications. Additionally, the company’s AI models are designed to predict potential biomarkers for the early detection of Alzheimer’s, optimize clinical trials and predict affinity to other neurological disorders, GLP-1, GIP, CB1 receptors, among others. With 28 patent filings and a commitment to innovation, IGC Pharma is dedicated to advancing pharmaceutical treatments and improving the lives of those affected by Alzheimer’s and related conditions. For more information, visit the company’s website at www.IGCInc.us.

NOTE TO INVESTORS: The latest news and updates relating to IGC are available in the company’s newsroom at https://ibn.fm/IGC

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

ESGBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Schedules Date for Release of Q2 2024 Financial Results, Conference Call

August 9, 2024 13:32:57

EverGen (TSX.V: EVGN) (OTCQX: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, will be releasing its second-quarter 2024 financial results on Aug. 21, 2024, after the market closes. The company also announced that it will host a results and corporate update conference call beginning at 4 p.m. ET the next day, Aug. 22, 2024. The Zoom call will be hosted by EverGen CEO Mischa Zajtmann and CFO Sean Hennessy.

The company also noted that, in accordance with the equity incentive plan, it had granted a total of 69,354 restricted share units and 94,141 stock options to certain executive officers of the company. “Each stock option is exercisable into one common share of the company at an exercise price of $2.21 per share for a seven-year period from the date of the grant and vest annually over a three-year period,” the company stated in the press release.

To view the call, visit https://ibn.fm/kQRgv

To view the full press release, visit https://ibn.fm/EF8UP

About EverGen Infrastructure Corp.

EverGen, Canada’s renewable natural gas infrastructure platform, is combating climate change and helping communities contribute to a sustainable future. Headquartered on the west coast of Canada, EverGen is an established independent renewable energy producer that acquires, develops, builds, owns and operates a portfolio of renewable natural gas, waste-to-energy and related infrastructure projects. EverGen is focused on Canada, with continued growth expected across other regions in North America and beyond. For more information about EverGen and its products, visit www.EverGenInfra.com.

NOTE TO INVESTORS: The latest news and updates relating to EVGIF are available in the company’s newsroom at https://ibn.fm/EVGIF

About ESGWireNews

ESGWireNews (“ESG”) is a specialized communications platform with a focus on the Environmental, Social and Governance (ESG) sector and public companies committed to sustainable corporate practices. ESGWireNews is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, ESG is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, ESG brings its clients unparalleled recognition and brand awareness. ESG is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from ESGWireNews, text “ESG” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.ESGWireNews.com

Please see full terms of use and disclaimers on the ESGWireNews website applicable to all content provided by ESG, wherever published or re-published: https://www.ESGWireNews.com/Disclaimer

ESGWireNews
Los Angeles, CA
www.ESGWireNews.com
310.299.1717 Office
[email protected]

ESGWireNews is powered by IBN

BillionDollarBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Releases Q2 2024 Financial Results Showing ‘Traction on All Fronts’

August 9, 2024 13:24:19

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, today announced financial results for the second quarter of fiscal 2024 (“Q2 2024”) ended June 30, 2024, and provided recent business and technical highlights. The company’s Q2 2024 revenue was $2.2 million, an increase of 28% from Q2 2023 revenue of $1.7 million, while Q2 2024 Bookings (*) were $2.7 million, a 6% increase from Q2 2023 Bookings of $2.5 million. According to the announcement, this represents D-Wave’s ninth consecutive quarter of year-over-year growth in quarterly Bookings. In addition, GAAP gross profit for Q2 2024 was $1.4 million, an increase of 97% from the Q2 2023 gross profit of $0.7 million. As of June 30, 2024, D-Wave’s consolidated cash balance totaled $40.9 million, an increase of $33.4 million, or 444%, from the Q2 2023 consolidated cash balance of $7.5 million.

“Our second quarter results show continued traction on all fronts – revenue, bookings, customer acquisition, liquidity and technical advancements,” said Dr. Alan Baratz, CEO of D-Wave. “There is rapidly growing awareness of annealing quantum computing and its ability to deliver business benefits today, and the market is responding. This is further strengthened by our product development activities in hardware (Advantage2(TM) prototype), software (new nonlinear hybrid solver and fast anneal feature), and Quantum Artificial Intelligence. Our momentum as one of the few companies in the world leading the quantum transformation is evident.”

(*) “Bookings” is an operating metric that is defined as customer orders received that are expected to generate net revenues in the future. We present the operational metric of Bookings because it reflects customers’ demand for our products and services and to assist readers in analyzing our potential performance in future periods.

To view the full press release, visit https://ibn.fm/uxlzw

About D-Wave Quantum Inc.

D-Wave is a leader in the development and delivery of quantum computing systems, software and services, and is the world’s first commercial supplier of quantum computers—and the only company building both annealing quantum computers and gate-model quantum computers. The company’s mission is to unlock the power of quantum computing today to benefit business and society. D-Wave does this by delivering customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection and financial modeling. D-Wave’s technology has been used by some of the world’s most advanced organizations including Mastercard, Deloitte, Davidson Technologies, ArcelorMittal, Siemens Healthineers, Unisys, NEC Corporation, Pattison Food Group Ltd., DENSO, Lockheed Martin, Forschungszentrum Jülich, University of Southern California, and Los Alamos National Laboratory.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

Forward Looking Statements

Certain statements in this press release are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including the risks set forth under the heading “Risk Factors” discussed under the caption “Item 1A. Risk Factors” in Part I of our most recent Annual Report on Form 10-K or any updates discussed under the caption “Item 1A. Risk Factors” in Part II of our Quarterly Reports on Form 10-Q and in our other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this press release in making an investment decision, which are based on information available to us on the date hereof. We undertake no duty to update this information unless required by law.

About BillionDollarClub

BDC is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BillionDollarClub, text “Billion” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BillionDollarClub.com

BillionDollarClub
Los Angeles, CA
www.BillionDollarClub.com
310.299.1717 Office
[email protected]

BillionDollarClub is powered by IBN

InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Reports on Status of New Product, Investment in Celly Nutrition Corp.

August 9, 2024 13:10:12

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is providing a status report on its investment in Celly Nutrition Corp. A privately held Canadian company, Celly Nu is launching an innovative beverage product designed to assist in expediting alcohol metabolism and faster recovery from alcohol consumption.

According to the update, Celly Nu has announced the imminent launch of its revolutionary, great-tasting, scientifically backed product, unbuzzd(TM). The product will be available in 3-pack or 18-pack options, and the compact packages can easily be carried in a pocket or purse. A proprietary blend of vitamins, minerals and herbs, unbuzzd is designed by scientists for use anywhere and helps the body process alcohol faster, restore mental alertness and improve cognition.

“I am very proud of the Celly Nu and FSD Pharma teams for delivering on our promise of a great tasting and functional product built on science,” said Celly Nutrition CEO John Duffy in the press release. “The successfully completed first production run of unbuzzd stick packs is one of the final steps before our August launch.”

About Celly Nutrition Corp.

Celly Nutrition stands as a pioneering force in the wellness and recovery supplement landscape. With a commitment to innovation and quality, the company has secured an exclusive global licensing agreement with FSD Pharma, harnessing cutting-edge alcohol metabolizing technology for recreational uses. This strategic move positions Celly Nutrition as a leader in the development of science-driven solutions designed to enhance individual health and recovery processes, marking a new era in the support of responsible alcohol consumption.

To view the full press release, visit https://ibn.fm/IVNs2

About FSD Pharma Inc.

FSD is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (“Lucid”), FSD is focused on the research and development of its lead compound, Lucid-MS (formerly Lucid-21-302) (“Lucid-MS”). Lucid-MS is a patented new chemical entity shown in preclinical models to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. FSD Pharma has also licensed unbuzzd(TM), a proprietary formulation of natural ingredients, vitamins and minerals to help with liver and brain function for the purposes of quickly relieving individuals from the effects of alcohol consumption for use in the consumer recreational sector, to Celly Nutrition Corp. FSD Pharma is entitled to a royalty on the revenue generated by Celly Nu from sales of products created using the technology rights granted under the licensing agreement. FSD Pharma continues its R&D activities to develop novel formulations for alcohol misuse disorders and continues the development of such treatments for use in the healthcare sector. FSD maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represent loans secured by residential or commercial property. For more information about the company, please visit www.FSDPharma.com.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

GreenEnergyBreaks — Expion360 Inc. (NASDAQ: XPON) Closes on Underwritten Public Offering Estimated at $10M Value

August 9, 2024 13:05:48

Expion360 (NASDAQ: XPON), a lithium-ion battery power storage solutions company, has closed on a firm commitment underwritten public offering. According to the announcement, the offering is estimated to result in $10 million gross proceeds before standard deductions. The offering is comprised of 50,000,000 common units or prefunded units, with each unit consisting of one share of XPON common stock or one prefunded warrant to purchase one share of common stock, two Series A warrants each to purchase one share of common stock, and one Series B warrant to purchase such number of shares of common stock as determined in the Series B warrant.

Expion360 anticipates using the funds from the offering to fully repay its outstanding debt as well as for working capital and general corporate purposes.

Aegis Capital Corp. acted as sole bookrunner for the offering. Expion360 granted Aegis Capital a 45-day option to purchase additional shares of common stock and/or prefunded warrants and/or common warrants solely to cover overallotments, if any.

To view the full press release, visit https://ibn.fm/JedDu

About Expion360 Inc.

Expion360 designs, assembles, manufactures and sells lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles, marine applications and home-energy storage products with plans to expand into industrial applications. For more information about the company, visit www.Expion360.com.

About GreenEnergyStocks

To receive SMS alerts from GreenEnergyStocks, text “Green” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenEnergyStocks.com

Please see full terms of use and disclaimers on the GreenEnergyStocks website applicable to all content provided by GES, wherever published or re-published: https://www.greennrgstocks.com/Disclaimer

GreenEnergyStocks
Los Angeles, CA
www.GreenEnergyStocks.com
310.299.1717 Office
[email protected]

GreenEnergyStocks is powered by IBN

AINewsBreaks – Alphabet Inc. (NASDAQ: GOOGL) Faces Antitrust Scrutiny Amid Market Dominance

August 9, 2024 13:00:03

Alphabet (NASDAQ: GOOGL, GOOG), the parent company of Google, is currently facing a challenging period, with antitrust scrutiny at the forefront of its concerns. Despite the complexities surrounding the antitrust ruling, experts from Barron’s suggest that Google’s market dominance is unlikely to be significantly impacted by the label of being a monopolist. However, it’s important to note that other risks loom large, potentially threatening the tech giant’s position.

The recent performance of Alphabet Inc.’s stock reflects the company’s current challenges and investor sentiment. With a closing price of $159.89, down $2.15 or -1.32%, the market is reacting to the ongoing developments. The stock’s movement within the day, ranging from a low of $159.06 to a high of $161.05, indicates the volatility and uncertainty that currently surrounds the company.

Over the past year, GOOGL’s stock has experienced significant fluctuations, with prices ranging from a low of $120.21 to a high of $191.75. This volatility highlights the impact of both internal and external factors on Alphabet’s market valuation. With a market capitalization of approximately $1.98 trillion, Alphabet remains one of the largest and most influential companies in the tech sector, despite the challenges it faces.

The trading volume of 10,064,492 shares further demonstrates the high level of investor interest and activity surrounding Alphabet Inc. This interest is likely driven by the company’s fundamental strengths, including its dominant position in the search engine market, as well as the potential risks and challenges highlighted by the antitrust scrutiny.

As Alphabet Inc. navigates through these turbulent times, the company’s stock performance and market valuation will continue to be closely watched by investors and analysts alike. The balance between maintaining its market dominance and addressing the concerns raised by antitrust rulings will be crucial for Alphabet’s future success and stability in the tech industry.

To view the company’s latest earnings release, visit https://ibn.fm/1vFFk

About Alphabet Inc.

Alphabet is a collection of companies, the largest of which is Google. Larry Page and Sergey Brin founded Google in September 1998 and the company is headquartered in Mountain View, Calif. Billions of people use its wide range of popular products and platforms each day, like Search, Ads, Chrome, Cloud, YouTube and Android. For more information, visit the company’s website at www.ABC.xyz.

About AINewsWire

AINewsWire (“AINW”) is a specialized communications platform with a focus on the latest advancements in artificial intelligence (“AI”), including the technologies, trends and trailblazers driving innovation forward. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, AINW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, AINW brings its clients unparalleled recognition and brand awareness.

AINW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from AINewsWire, text “AI” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit www.AINewsWire.com

Please see full terms of use and disclaimers on the AINewsWire website applicable to all content provided by AINW, wherever published or re-published: https://www.AINewsWire.com/Disclaimer

AINewsWire
Los Angeles, CA
www.AINewsWire.com
310.299.1717 Office
[email protected]

AINewsWire is powered by IBN

TechMediaBreaks – SenesTech Inc. (NASDAQ: SNES) Releases Q2 2024 Financial, Corporate Report

August 9, 2024 12:50:59

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal-pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control(R), is reporting on its second-quarter 2024 financial results. According to the report, the company saw record revenue of $874,000 in the first half of 2024, a 62% increase when compared to the first half of 2023, as well as improvement in margin percentages.

In addition, the report noted key performance indicators, such as SenesTech’s Evolve(TM) product line, which was launched this year, becoming the company’s biggest-selling product line, contributing some 60% revenue this year’s numbers. The report also noted that significant third-party efficacy trials have begun.

“The second-quarter results highlight yet another quarter of record top line sales,” said SenesTech president and CEO Joel Fruendt in the press release. “Sixty-two percent growth year to date versus the same period in 2023, as well as strong operational improvement of numerous key metrics have reduced our cash burn as we look to achieve our near-term objective of profitability. Importantly, we are ideally positioned to see accelerating growth due to the initiatives we put in place throughout the first half of 2024, including the launch of Evolve for rats with key online retailers; the launch of our new Evolve Mouse solution; the ramp up of recently secured distribution agreements; and new product packing options.”

To view the full press release, visit https://ibn.fm/RJNDj

About SenesTech Inc.

SenesTech is committed to improving the health of the world by humanely managing animal-pest populations through fertility control. SenesTech invented ContraPest, the only U.S. EPA-registered contraceptive for male and female rats, as well as Evolve and Evolve Mouse, an EPA-designated, minimum-risk contraceptive for rodents, reflecting the company’s mission to provide products that are proactive, safe and sustainable. ContraPest and Evolve fit seamlessly into all integrated pest-management programs, significantly improving the overall goal of effective pest management. SenesTech strives for clean cities, efficient businesses and happy households — with a product designed to be humane, effective and sustainable. For more information about the company, please visit www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
[email protected]

TechMediaWire is powered by IBN

MiningNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Comments on Argentine Legislation, Mining Transaction and Los Azules Infill Drilling

August 9, 2024 12:37:50

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, is sharing updates regarding the current mining situation in Argentina. Calling the situation “exciting,” MUX noted that Argentine president Javier Milei had introduced new legislation encouraging large domestic and foreign investments in the country. The company observed that it is excited about the legislation because it opens the door for many infrastructure investments in the country and has potential to significantly improve the economics of the Los Azules project while lowering risks for investors.

The company also noted that the world’s largest mining company, BHP, and Lundin Mining had been involved in a $4.4 billion joint acquisition of two copper deposits, which are located in the same province in Argentina as McEwen Mining’s Los Azules. McEwen called this a “convincing demonstration” of San Juan and Argentina´s attractiveness for large-scale mining projects and evidence of Argentina working to become a tier 1 mining jurisdiction.

McEwen also reported that infill drilling at Los Azules is now complete. “At Los Azules, infill drilling upgraded the resource categories, validated the geological model and confirmed the high-grade zone,” said the company in the press release. “During the 2023–2024 drilling season, over 70,000 meters were completed, that have strengthened the interpretation of the geological model in addition to extending the supergene enrichment zone mineralization, both at the edges and to depth. Resource drilling for the Los Azules Feasibility Study is now complete, and the study remains on track for delivery in early 2025.”

To view the full press release, visit https://ibn.fm/Ea9eH

About McEwen Mining Inc.

McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. The company also owns a 48.3% interest in McEwen Copper, which is developing the large, advanced-stage Los Azules copper project in Argentina. The company’s objective is to improve the productivity and life of its assets with the goal of increasing the share price and providing investor yield. Rob McEwen, chair and chief owner, has a personal investment in the companies of $225 million. His annual salary is $1. To learn more about the company, visit www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at https://ibn.fm/MUX

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

US Coal Stocks Reach Highest Level Since 2020

August 9, 2024 10:05:00

Latest data released by the Energy Information Administration shows that electric power plants in the United States held 138 million tons of coal by May’s end. According to the agency, this is the highest level since the drop in the demand for coal and power recorded at the beginning of the pandemic in 2020.

Overall, the share of coal used to generate power in the country over the last couple of years has greatly decreased. This has, in…

NOTE TO INVESTORS: The latest news and updates relating to Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) are available in the company’s newsroom at https://ibn.fm/ATBHF

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

Taipei Emerges as Asia’s Premier Hub for AI, Web3 Innovation

August 9, 2024 10:05:00

Taipei is quickly proving that it is a central hub for Web3 and artificial intelligence (AI) innovation in the Asian continent. The upcoming Asia Blockchain Summit 2024 (ABS2024), set to take place from Aug. 6–8, 2024, at the Taipei Nangang Exhibition Center, epitomizes this transformation.

The high-profile event, organized by BlockTempo, a blockchain news media powerhouse, will showcase the city’s leadership in Web3 technology and…

NOTE TO INVESTORS: The latest news and updates relating to NextPlat Corp. (NASDAQ: NXPL, NXPLW) are available in the company’s newsroom at https://ibn.fm/NXPL

About Web3MediaWire

Web3MediaWire (“W3MW”) is a specialized communications platform with a focus on the next generation of internet technologies. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, W3MW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, W3MW brings its clients unparalleled recognition and brand awareness. W3MW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from Web3MediaWire, text “Web3” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.Web3MediaWire.com

Please see full terms of use and disclaimers on the Web3MediaWire website applicable to all content provided by W3MW, wherever published or re-published: https://www.Web3MediaWire.com/Disclaimer

Web3MediaWire
Los Angeles, CA
www.Web3MediaWire.com
310.299.1717 Office
[email protected]

Web3MediaWire is powered by IBN

‘Revolutionary’ AI Uncovers Hidden Risks of Heart Attacks

August 9, 2024 10:05:00

Data from the British Heart Foundation estimates that roughly 7.6 million individuals in the United Kingdom are living with heart disease. Now scientists have designed an artificial intelligence model that can spot inflammation in the heart, making it easier to identify those at risk of a cardiac arrest.

The focus on inflammation is based on research which has determined that increased inflammation is associated with a heightened risk of…

About AINewsWire

AINW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from AINewsWire, text “AI” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit www.AINewsWire.com

Please see full terms of use and disclaimers on the AINewsWire website applicable to all content provided by AINW, wherever published or re-published: https://www.AINewsWire.com/Disclaimer

AINewsWire
Los Angeles, CA
www.AINewsWire.com
310.299.1717 Office
[email protected]

AINewsWire is powered by IBN

Australia Launches Novel Immunotherapy Program to Help Babies with Peanut Allergies

August 9, 2024 10:05:00

Australia recently launched a countrywide immunotherapy program for infants with peanut allergies. The program is a partnership between the Murdoch Children’s Research Institute and the country’s National Allergy Center of Excellence. This is the first time a countrywide program for peanut allergies is being integrated into mainstream care globally.

The program, whose objective is to safely build tolerance and hopefully achieve remission, is available for babies under 12 months who have been…

NOTE TO INVESTORS: The latest news and updates relating to Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) are available in the company’s newsroom at https://ibn.fm/SCNI

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

EV Sales Forecast Slashed as ‘Overriding Concern’ Bothers Industry

August 9, 2024 10:05:00

The Society of Motor Manufacturers and Traders (SMMT) in the United Kingdom has slashed its forecast for electric-vehicle sales as the market continues to deal with low demand. The trade body noted that more action has to be taken to encourage electric-vehicle adoption among consumers. This statement comes at a time when the burgeoning electric vehicle industry is plagued with waning demand and dwindling sales as high costs discourage drivers from making the transition to electric cars.

Dwindling electric-vehicle demand is likely the primary reason behind the SMMT lowering its new-vehicle registration forecast for 2024 from…

NOTE TO INVESTORS: The latest news and updates relating to Mullen Automotive Inc. (NASDAQ: MULN) are available in the company’s newsroom at https://ibn.fm/MULN

About GreenCarStocks

GreenCarStocks (“GCS”) is a specialized communications platform with a focus on electric vehicles (“EVs”) and the green energy sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled recognition and brand awareness. GCS is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from GreenCarStocks, text “Green” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the GreenCarStocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

GreenCarStocks
Los Angeles, CA
www.GreenCarStocks.com
310.299.1717 Office
[email protected]

GreenCarStocks is powered by IBN

Alibaba Sets Date to Release Latest Quarterly Results

August 9, 2024 10:05:00

Alibaba Group Holding Ltd. (NYSE: BABA) has set the date for the official release of its latest quarter reports. According to an announcement from the Chinese company, unaudited financial outcomes for the June quarter are set to be released on Aug. 15, 2024, prior to the opening of the American market. Alibaba will also conduct a conference call at 19:30 Hours Hong Kong Time (07:30 hours ET) on that day to discuss the financial results.

Individuals interested in joining the call will have to go through a preregistration process where they will receive a special access pin, passcode and…

About ChineseWire

For more information, please visit https://www.ChineseWire.com

Please see full terms of use and disclaimers on the ChineseWire website applicable to all content provided by CW, wherever published or re-published: https://www.ChineseWire.com/Disclaimer

ChineseWire
Los Angeles, CA
www.ChineseWire.com
310.299.1717 Office
[email protected]

ChineseWire is powered by IBN

The Market for ESG Software Project to Hit $2.5B Valuation by 2028

August 9, 2024 10:05:00

Environmental, social and governance (ESG) reporting software contains different solutions and modules focused on regulatory, risk management, safety, health and compliance. This software is used to manage a company’s ESG data in one system that is available in a format where the data is finance grade and auditable.

The market for this software has experienced strong growth in the last couple of years, growing to $1.19 billion this year from…

NOTE TO INVESTORS: The latest news and updates relating to Energy and Water Development Corp. (OTCQB: EAWD) are available in the company’s newsroom at https://ibn.fm/EAWD

About ESGWireNews

To receive SMS alerts from ESGWireNews, text “ESG” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.ESGWireNews.com

Please see full terms of use and disclaimers on the ESGWireNews website applicable to all content provided by ESG, wherever published or re-published: https://www.ESGWireNews.com/Disclaimer

ESGWireNews
Los Angeles, CA
www.ESGWireNews.com
310.299.1717 Office
[email protected]

ESGWireNews is powered by IBN

Analysis Shows Recalls Woefully Slow in Removing Potentially Contaminated Cannabis from Circulation

August 9, 2024 10:05:00

A recently conducted analysis has determined that most cannabis recalls are circulated too late, even when products contain unhealthy levels of pesticides or mold. This comes at a time when a growing number of people are raising concerns about product safety.

The analysis focused on product recalls in the following state-regulated cannabis markets: New York, Michigan, Massachusetts, Colorado and…

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

Crypto Fest 2024 – Returns for its 6th Edition, Cape Town, South Africa

August 9, 2024 09:35:00

Join the crypto saga as Crypto Fest returns with its 6th edition, bringing together the dynamic African crypto and blockchain community in the picturesque city of Cape Town, South Africa on October 10-12th, 2024. This year Crypto Fest 2024 expands over three days with the main event on the 11 October taking place at the iconic DHL Stadium, home to the FIFA World Cup in 2010 a centrally located iconic landmark with excellent facilities, accessibility, and a rich legacy.

Bitcoin Events has been the proud host of Crypto Fest for the last five years, and has witnessed thousands of attendees from 120 countries, 5 events, and 160+ speakers thus far. The event brings together executives, professionals, innovators and brands from the realms of…

To learn more, please visit https://ccw.fm/bpHWc

About CryptoCurrencyWire

To receive SMS alerts from CryptoCurrencyWire, text “CRYPTO” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CryptoCurrencyWire.com

CryptoCurrencyWire
New York, NY
www.CryptoCurrencyWire.com
212.994.9818 Office
[email protected]

CryptoCurrencyWire is powered by IBN

Astiva Health Inc. Focused on Establishing Lifelong Relationships, Providing Tailored Healthcare Approach to Underserved Populations

August 9, 2024 08:50:00

Survey indicates sizable proportion of older adult population copes with healthcare costs by skipping treatments, cutting back on basic and essential needs
Astiva Health is keenly aware of problems faced by underserved senior population
The company strives to bridge healthcare gaps through proactive, culturally responsive solutions

As growing numbers of the U.S. population reach age 65, the challenge of adequate healthcare becomes even more critical. In fact, a West Health-Gallup survey reports that some elderly are forgoing needed care because of healthcare costs (https://ibn.fm/pJGqA). Astiva Health, a dynamic and innovative Medicare Advantage Prescription Drug (“MAPD”) health plan, is on a mission to meet the challenges faced by underserved aging populations by reshaping the landscape of personalized and comprehensive healthcare.

“The West Health-Gallup survey shows that a sizable proportion of the older adult population copes with healthcare costs by skipping treatments and cutting back on basic and essential needs,” the Gallup report stated. “The avoidance of vital medical care could compound negative health outcomes now and in the…

NOTE TO INVESTORS: The latest news and updates relating to Astiva Health are available in the company’s newsroom at https://ibn.fm/Astiva

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

Coinbase’s Q2 Report Reveals Strong Performance

August 9, 2024 08:05:00

Coinbase Global Inc. (NASDAQ: COIN), one of the leading cryptocurrency exchanges in the world, recently released its second quarterly report, and the performance is impressive. While the compay has had its share of ups and downs, this latest financial report suggests that the team is keeping the boat steady.

The company reported total revenue of $1.45 billion for Q2 2024, an increase from $708 million a year ago. This figure surpassed estimates of Wall Street analysts, an indication of its operational strength, especially at a challenging period for crypto trading. The company has faced a decline in transaction…

About BillionDollarClub

BDC is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BillionDollarClub, text “Billion” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BillionDollarClub.com

BillionDollarClub
Los Angeles, CA
www.BillionDollarClub.com
310.299.1717 Office
[email protected]

BillionDollarClub is powered by IBN

FBI Warns Public Against Scammers Posing as Crypto Exchange Workers

August 9, 2024 08:05:00

Bitcoin and other leading cryptocurrencies, including XRP, Ethereum and Solana, have seen a significant decline this week, mirroring the downturn in the stock market, which could potentially worsen. The price of Bitcoin has fallen to around $60,000 after reaching $70,000 only a week earlier. Similarly, XRP, Ethereum and Solana have also experienced drops, collectively erasing $300 billion from the cryptocurrency market since the end of July.

As traders prepare for a potentially significant impact on Bitcoin stemming from actions by U.S. presidential candidate Donald Trump, the FBI has issued a stern warning regarding cryptocurrency scams. The FBI cautioned about scammers pretending to be employees of cryptocurrency exchanges with the…

About CryptoCurrencyWire

To receive SMS alerts from CryptoCurrencyWire, text “CRYPTO” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CryptoCurrencyWire.com

CryptoCurrencyWire
New York, NY
www.CryptoCurrencyWire.com
212.994.9818 Office
[email protected]

CryptoCurrencyWire is powered by IBN

Wisconsin Energy Regulators to Make Unprecedented Decisions as State Goes Green

August 9, 2024 08:05:00

Energy regulators in Wisconsin are poised to make decisions unprecedented in the state’s history as it speeds up its transition to clean energy. Renewables accounted for only 3% of Wisconsin’s capacity in 2008, but now the Badger State draws a whopping 28% of its energy from green sources such as solar and wind.

While this pales in comparison to what many European countries have achieved, it is a monumental achievement for Wisconsin and a stepping stone to even greater successes in the…

NOTE TO INVESTORS: The latest news and updates relating to First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) are available in the company’s newsroom at https://ibn.fm/FSTTF

About GreenEnergyStocks

To receive SMS alerts from GreenEnergyStocks, text “Green” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenEnergyStocks.com

Please see full terms of use and disclaimers on the GreenEnergyStocks website applicable to all content provided by GES, wherever published or re-published: https://www.greennrgstocks.com/Disclaimer

GreenEnergyStocks
Los Angeles, CA
www.GreenEnergyStocks.com
310.299.1717 Office
[email protected]

GreenEnergyStocks is powered by IBN

D-Wave Quantum Inc. (NYSE: QBTS) Expands Commercial Partnership with Zapata Computing Holdings Inc. (NASDAQ: ZPTA), Hosts B.C. Dignitaries at Quantum Engineering Center of Excellence

August 9, 2024 08:05:00

The collaboration aims to enhance the development and deployment of integrated quantum and generative AI solutions within D-Wave’s Leap™ quantum cloud platform
The partnership’s development efforts will target more efficient and energy-saving model training, higher-performing models, and the combined application of Generative AI and quantum optimization
The commercial expansion includes a one-year enterprise subscription to Orquestra®, Zapata AI’s powerful software development and collaboration platform designed for creating and deploying Universal Generative AI applications at scale
D-Wave recently hosted British Columbia (B.C.) Minister of State for Trade, Jagrup Brar, and B.C. Parliamentary Secretary for Labour, Janet Routledge, at its Burnaby-based Quantum Engineering Center of Excellence

D-Wave Quantum (NYSE: QBTS), a pioneer in quantum computing systems, software, and services, and Zapata Computing Holdings (NASDAQ: ZPTA), known for its expertise in industrial generative AI software solutions, have announced a notable expansion of their commercial partnership. The collaboration aims to accelerate the development and deployment of integrated quantum and generative AI solutions in D-Wave’s Leap quantum cloud platform (https://ibn.fm/jcUJp).

The expanded agreement will utilize Zapata’s proprietary universal generative AI software for rapid development and build on D-Wave’s Leap real-time quantum cloud service to support quantum, hybrid quantum, and classical AI solutions. The partnership’s development efforts will target more efficient and…

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

Forward-Looking Statements

Certain statements in this press release are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including the risks set forth under the heading “Risk Factors” discussed under the caption “Item 1A. Risk Factors” in Part I of the company’s most recent Annual Report on Form 10-K or any updates discussed under the caption “Item 1A. Risk Factors” in Part II of the company’s Quarterly Reports on Form 10-Q and in the company’s other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this press release in making an investment decision, which are based on information available to the company on the date hereof. The company undertakes no duty to update this information unless required by law.

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
[email protected]

TechMediaWire is powered by IBN

420 with CNW — New Poll Suggests Florida Cannabis Ballot Measure Has Ample Bipartisan Support to Pass

August 8, 2024 15:25:00

A new survey reveals that Florida’s initiative to legalize marijuana, set to be on the ballot in November, has enough support to potentially pass, boasting majority approval across various demographic groups.

The poll, conducted by the University of North Florida (UNF), indicates that 64% of likely voters favor the marijuana reform proposal. This percentage exceeds the…

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

TechMediaBreaks – PayPal Holdings Inc. (NASDAQ: PYPL) Launches Fastlane to Enhance E-Commerce Checkout Experience

August 8, 2024 14:56:09

PayPal Holdings (NASDAQ: PYPL) is making significant strides in the e-commerce sector with the launch of Fastlane, a service aimed at enhancing the online shopping experience. As a leading entity in digital payments, PayPal’s introduction of Fastlane underscores its commitment to streamlining the checkout process for businesses and consumers alike. This move comes at a crucial time, just before the holiday shopping season, positioning PayPal to capitalize on the increased online shopping activity.

Fastlane is designed to address a critical consumer demand for quicker and more convenient checkout processes. Research by Capterra reveals a clear consumer preference for online guest checkout, with a significant portion of shoppers favoring this option due to its speed and simplicity. Fastlane’s ability to reduce checkout times to potentially a single click aligns perfectly with these consumer expectations, offering a seamless shopping experience that could significantly boost merchant sales and customer loyalty.

The effectiveness of Fastlane is already evident through its early adoption by businesses such as Black Forest Decor and BigCommerce. These companies have reported remarkable improvements in conversion rates and checkout times, highlighting Fastlane’s potential to transform the online shopping experience. By enabling a faster checkout process, Fastlane not only meets consumer expectations but also provides a competitive edge to businesses in the crowded online marketplace.

Moreover, PayPal’s stock performance, as highlighted by its current trading status, reflects the company’s strong position in the market. With a market capitalization of around $65.44 billion and a notable increase in its stock price, PayPal demonstrates robust financial health and investor confidence. This financial stability is crucial as it supports PayPal’s ongoing efforts to innovate and expand its services, such as Fastlane, across the global commerce landscape.

PayPal’s strategic focus on enhancing the e-commerce experience through Fastlane, coupled with its solid financial performance, positions the company as a key player in the digital payments industry. As Fastlane becomes available on more platforms and to a wider range of merchants, PayPal is set to further solidify its role in facilitating efficient and secure online transactions, benefiting both businesses and consumers worldwide.

To view the full press release, visit https://ibn.fm/bPEMd

About PayPal

PayPal has been revolutionizing commerce globally for more than 25 years. Creating innovative experiences that make moving money, selling, and shopping simple, personalized, and secure, PayPal empowers consumers and businesses in approximately 200 markets to join and thrive in the global economy. For more information, visit www.PayPal.com.

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
[email protected]

TechMediaWire is powered by IBN

GreenEnergyBreaks — Mullen Automotive Inc.’s (NASDAQ: MULN) Boston Area Dealer Plans Expansion to Meet Demand, Makes New Order

August 8, 2024 14:46:20

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that its Boston area dealer, Eco Auto, a dedicated EV dealer, intends to expand to cover national fleet opportunities in Pennsylvania, Connecticut, Rhode Island, New Hampshire, Maine and Vermont. The expansion aims to meet the growing demand for commercial EVs and support Mullen’s full line of commercial EVs in these regions. Eco Auto’s expansion includes the purchase of 180 EVs (130 Mullen Class 1 EV cargo vans and 50 Class 3 EV trucks) over the next 18 months. The order is valued at an estimated $7.7 million, with new deliveries expected to begin in September 2024. “Our Commercial EVs are extremely versatile for use across multiple sectors,” said David Michery, CEO and chairman of Mullen Automotive. “This order and the expansion of Evo Auto to meet demand demonstrates that Mullen EVs are the preferred choice for fleet operators across the nation seeking sustainable transportation solutions.”

To view the full press release, visit https://ibn.fm/EMlBF

About Mullen Automotive Inc.

Mullen is a Southern California-based automotive company building the next generation of commercial electric vehicles (“EVs”) with two United States-based vehicle plants located in Tunica, Mississippi (120,000 square feet) and Mishawaka, Indiana (650,000 square feet). In August 2023, Mullen began commercial vehicle production in Tunica. In September 2023, Mullen received IRS approval for federal EV tax credits on its commercial vehicles with a Qualified Manufacturer designation that offers eligible customers up to $7,500 per vehicle. As of January 2024, both the Mullen ONE, a Class 1 EV cargo van, and Mullen THREE, a Class 3 EV cab chassis truck, are California Air Resource Board (“CARB”) and EPA certified and available for sale in the U.S. For more information about the company, visit www.MullenUSA.com.

NOTE TO INVESTORS: The latest news and updates relating to MULN are available in the company’s newsroom at https://ibn.fm/MULN

About GreenEnergyStocks

To receive SMS alerts from GreenEnergyStocks, text “Green” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenEnergyStocks.com

Please see full terms of use and disclaimers on the GreenEnergyStocks website applicable to all content provided by GES, wherever published or re-published: https://www.greennrgstocks.com/Disclaimer

GreenEnergyStocks
Los Angeles, CA
www.GreenEnergyStocks.com
310.299.1717 Office
[email protected]

GreenEnergyStocks is powered by IBN

TechMediaBreaks – Authentic Holdings Inc. (OTC: AHRO) Subsidiary Inks Global Licensing Agreement with Leading Provider of Smart-Home Solutions, Services

August 8, 2024 14:29:20

Authentic Holdings’ (OTC: AHRO), a vertically and horizontally integrated media and merchandising company, and its subsidiary, Maybacks Global Entertainment, have signed a license and partnership agreement with ZEASN Technology Private Limited. According to the announcement, the agreement provides Maybacks with “a massive footprint” to market its iDreamCTV SMART TV APP.

The agreement outlines plans for Maybacks Global Entertainment to partner with ZEASN subsidiary Whale Echo, the world’s leading provider of smart-home solutions and services. Whale Echo has more than 180 million users of its products worldwide. The two entities are finalizing the design of a banner ad that will appear throughout the Whale Echo Smart TV eco-system.

“We are extremely excited to be working with ZEASN and their Whale Echo products(s),” said Authentic Holdings president Chris Giordano in the press release. “ZEASN is at the forefront of Smart TV innovation. . . . Whale Echo will be marketing and advertising both of our iDreamCTV App and our Vast Tag advertising program across the entire Whale Echo footprint. In essence, Whale Echo will comarket our APP and Vast Tag ads where both parties to the joint venture benefit through the monetization of the Vast Tag program. This is a watershed deal for Authentic Holdings.”

To view the full press release, visit https://ibn.fm/jI42r

About Authentic Holdings Inc.

Authentic Holdings is both a vertically and horizontally integrated media and merchandising company that combines broadcasting, content-owned entertainment, patented technology and merchandise using its Maybacks television networks to both generate ad revenue as well as support its other product lines. For more information about the company, visit www.AuthenticHoldings.com.

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
[email protected]

TechMediaWire is powered by IBN

TechMediaBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Enters New Partnership with IGNITION IR to Enhance Visibility with Investment Community

August 8, 2024 14:00:00

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), an innovative logistics technology solutions company offering its custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine learning that offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region, today announced that it has engaged IGNITION Investor Relations, a New Jersey based firm, to provide market awareness and investor relations (“IR”) services to the company. This new partnership is part of Fr8Tech’s ongoing strategy to enhance its visibility with the institutional and retail investment community. “The Ignition team has significant and highly relevant IR experience as well as an outstanding investment community network, which we believe will complement the leadership of Fr8Tech as we work together to communicate our value to investors,” said Donald Quinby, CFO of Fr8Tech.

To view the full press release, visit https://ibn.fm/JckXM

About Freight Technologies Inc.

Freight Technologies (“Fr8Tech”) is a technology company developing solutions to optimize and automate the supply chain process. Its wholly owned subsidiary, Freight App Inc. (“Fr8App”), is a B2B cross-border shipping marketplace in the USMCA region powered by AI and machine learning. Focused on making shipping transparent and efficient, Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility and simplicity for the once-complex process of international over-the-road (“OTR”) shipping. Fr8App uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via innovative technologies such as live pricing, real-time tracking, digital freight marketplace dashboards, brokerage matching, transportation management, fleet management, and committed capacity solutions. The company is headquartered in Houston, Texas. For more information, please visit Fr8Technologies.com.

NOTE TO INVESTORS: The latest news and updates relating to FRGT are available in the company’s newsroom at https://ibn.fm/FRGT

Corporate Communications
IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
[email protected]

TechMediaWire is powered by IBN

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Inks Two New Contracts, Announces Q2 2024 Town Hall

August 8, 2024 13:50:20

Knightscope (NASDAQ: KSCP), an innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, has signed two contracts with two clients: a Colorado ski resort, which is a new client, and a Southern California municipality, which expanded its existing KSCP contract.

According to the announcement, the ski resort purchased a K1 Call Box for one of its ski lifts; the contract also included along KSCP’s Full-Service Maintenance Plan (“FSMP”) and the Knightscope Emergency Management System (“KEMS”) software, which monitors the status and activity of the device. The California municipality expanded its current agreement by adding installation and also including FSMP for its 10 K1 Blue Light Emergency Phones .

“The FSMP ensures the highest levels of reliability and ‘up-time’ for these critical points of communication needed to summon help in a time of crisis or distress for all clients,” stated KSCP in the announcement.

The company also announced the date for its second quarter 2024 Town Hall, which will be held on Aug. 15, 2024, at 2 p.m. ET. During the call, a prerecorded message from William Santana, Knightscope’s chair and CEO, and Li Apoorv S Dwivedi, Knightscope’s EVP and CFO, will be played. In addition, company leaders will host a live question-and-answer session with supporters, investors and analysts. The prerecorded portion of the town hall presentation will be available on the company website following the event.

To view the full press release, visit https://ibn.fm/hOWA6

About Knightscope, Inc.

Knightscope builds cutting-edge technologies to improve public safety. The company’s long-term ambition is to make the United States of America the safest country in the world. For more information about the company, please visit www.Knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP

About TinyGems

TinyGems is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems
Los Angeles, CA
www.TinyGems.com
310.299.1717 Office
[email protected]

TinyGems is powered by IBN

BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Reports on ‘Synergistic Effect’ of Lead Compound Plus GLP-1 in AD Treatment Model

August 8, 2024 13:07:59

Annovis Bio (NYSE: ANVS), a late-stage, clinical-drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), is reporting new preclinical data regarding buntanetap, its lead compound. According to the report, the date demonstrates the synergistic effect of buntanetap when combined with the glucagon-like peptide 1 (“GLP-1”) agonist dulaglutide (Trulicity[R]) in a mouse model of Alzheimer’s disease.

The announcement noted that the Alzheimer’s Disease Diagnostics and Therapeutics Market size is projected to reach $7.7 billion this year and grow to $10.1 billion by 2029. Major factors contributing to that growth include the increasing use of biomarkers in Alzheimer’s diagnosis and drug development and the rising prevalence of Alzheimer’s worldwide, the article observed. Active biotech, pharma companies interested in these markets this week include Merck & Co., Inc. (NYSE: MRK), Sanofi (NASDAQ: SNY), Johnson & Johnson (NYSE: JNJ) and Novartis AG (NYSE: NVS).

“In 2018, Annovis Bio published data showing that buntanetap fully restored memory, learning and synaptic potentiation in an Alzheimer’s mouse model,” the article stated. “Building on this research, Annovis recently investigated whether combining buntanetap with the GLP-1 agonist dulaglutide would produce a synergistic effect in the same animal model. The results were compelling: while buntanetap alone restored cognitive function to 100% and dulaglutide alone to 80%, the combination of these two compounds not only restored cognitive function but also enhanced it beyond levels seen in healthy controls.”

To view the full press release, visit https://ibn.fm/Ut8vA

About Annovis Bio Inc.

Annovis Bio is headquartered in Malvern, Pennsylvania, and is dedicated to addressing neurodegeneration in diseases such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”). The company’s innovative approach targets multiple neurotoxic proteins, aiming to restore brain function and improve the quality of life for patients. For more information about the company, visit www.AnnovisBio.com.

NOTE TO INVESTORS: The latest news and updates relating to ANVS are available in the company’s newsroom at https://ibn.fm/ANVS

For more information, visit the company’s website at www.AnnovisBio.com, and social channels LinkedIn, X and YouTube.

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) CEO Spotlighted in Recent BioMedWire Podcast Episode

August 8, 2024 12:36:16

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, was featured in the latest episode of the BioMedWire Podcast, which is part of a sustained effort by IBN (Investor Brand Network) to provide specialized content distribution via widespread syndication channels. During the episode, Clene CEO and president Rob Etherington talks with IBN’s Carmel Fisher about the company’s mission, including its novel approach to the treatment of diseases such as amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”).

“Clene Inc. is focused entirely on improving mitochondrial health and protecting neuron function,” said Clene CEO and president Rob Etherington in the press release. “We’re pioneering a very unique approach: the use of an oral suspension that patients can drink to treat the deficits that they might have if afflicted with one of these devastating neurodegenerative diseases. . . . Our drug enables the energetic capacity that those muscles require to function and, in the case of ALS, enables the main systems, primarily breathing, to be muscularly sustained so patients potentially have increased rates of survival, as our data suggests.”

To view the podcast, visit https://ibn.fm/a7e9u

To view the full press release, visit https://ibn.fm/KGwBG

About Clene Inc.

Clene and its wholly owned subsidiary, Clene Nanomedicine, is a late-clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease and multiple sclerosis. CNM-Au8(R) is an investigational, first-in-class therapy that improves the survival and function of central nervous system cells via a mechanism that targets mitochondrial function and the nicotinamide adenine dinucleotide (“NAD”) pathway while reducing oxidative stress. CNM-Au8 is a federally registered trademark of Clene Nanomedicine. The company is based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland. For more information, please visit www.Clene.com.

NOTE TO INVESTORS: The latest news and updates relating to CLNN are available in the company’s newsroom at https://ibn.fm/CLNN

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

BioMedNewsBreaks — Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Releases Q1 2025 Financial Results, Business Highlights

August 8, 2024 11:44:32

Cybin (NYSE American: CYBN) (Cboe CA: CYBN), a clinical-stage biopharmaceutical company developing new and innovative next-generation psychedelic-based treatment options, today reported unaudited financial results for its first quarter of fiscal 2025 ended June 30, 2024 (“Q1 2025”) and provided recent business highlights. In the report, the company noted continued progress towards initiating its Phase 3 multinational study for the CYB003 program in late summer of 2024.

The company reported that it has strengthened its research and development team with two key additions: Dr. Atul R. Mahableshwarkar M.D., DLFAPA, Senior Vice President, Clinical Development, and Dr. Tom Macek, Pharm.D., Ph.D., Senior Vice President, Clinical Development. Cybin also strengthened its intellectual property portfolio with additional patents in support of the CYB004 program. In addition, the report listed upcoming clinical milestones and future studies, including the CYB003, its deuterated psilocybin analog program, and CYB004, its deuterated DMT program.

Financial information for Q1 2025 included cash totaling C$183 million as of June 30, 2024; a net loss of C$15 million for the first quarter ended June 30, 2024, compared to a net loss of C$15 million in the same period last year; and cash-based operating expenses totaling C$16 million in Q1 2025, compared to C$11 million in the prior year quarter.

“During the recent quarter we continued to move quickly, having achieved meaningful progress on the development of our two lead product candidates: CYB003, our proprietary deuterated psilocybin analog program in development for the adjunctive treatment of Major Depressive Disorder, and CYB004, our proprietary deuterated dimethyltryptamine program in development for the treatment of Generalized Anxiety Disorder. The path towards approval and commercialization for our novel therapeutics is coming into focus as we work efficiently to provide improved outcomes for patients and their families,” said Doug Drysdale, CEO of Cybin.

To view the full press release, visit https://ibn.fm/Xjday

About Cybin Inc.

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. Cybin’s goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug discovery platforms, innovative drug delivery systems, and novel formulation approaches and treatment regimens. The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For company updates and to learn more about Cybin, visit www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

InvestorNewsBreaks – RYVYL Inc.’s (NASDAQ: RVYL) New License Agreement Leverages Core PPaaS Tech, Builds New Revenue Stream

August 8, 2024 11:27:24

RYVYL (NASDAQ: RVYL), a leading innovator of payment transaction solutions leveraging proprietary blockchain ledger and electronic payment technology for the diverse international markets, has licensed its payment-platform-as-a-service to a U.S. based licensee. According to the announcement, the licensee plans to deploy services nationwide for both card present (“CP”) and card not present (“CNP”) transactions, with RYVYL earning revenue on every transaction. The agreement capitalizes on RYVYL’s proprietary technology and creates revenue for the company in the fourth quarter.

“Leveraging our core technology to build a new high-margin revenue stream, we signed an exclusive U.S. license of our private label PPaaS platform, for a niche industry customer base,” said RYVYL cofounder and CEO Fredi Nisan in the press release. “In the third quarter of 2024, we delivered a private label instance of the product, which the licensing partner will complete API integration to its banking network by the end of Q3 and should start contributing revenue by Q4. We expect it will take time to ramp up transactions as the licensee begins to onboard their available portfolio of more than 1,000 merchants.”

To view the full press release, visit https://ibn.fm/kiyJ9

About RYVYL Inc.

RYVYL was born from a passion for empowering a new way to conduct business-to-business, consumer-to-business and peer-to-peer payment transactions around the globe. By leveraging proprietary blockchain ledger and electronic token technology for the diverse international markets, RYVYL is a leading innovator of payment transaction solutions reinventing the future of financial transactions. Since its founding as GreenBox POS in 2017 in San Diego, RYVYL has developed applications enabling an end-to-end suite of turnkey financial products with enhanced security and data privacy, world-class identity-theft protection and rapid speed to settlement. As a result, the platform can log immense volumes of immutable transactional records at the speed of the internet for first-tier partners, merchants and consumers around the globe. For more information about the company, please visit www.RYVYL.com.

NOTE TO INVESTORS: The latest news and updates relating to RVYL are available in the company’s newsroom at https://ibn.fm/RVYL

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – MetAlert Inc. (MLRT) Selects TEAL to Support Rollout of Its GunAlert and SmartSole Products

August 8, 2024 11:22:46

MetAlert (OTC: MLRT), a pioneer in the field of wearable GPS human and high value asset tracking, today announced a partnership with TEAL. According to the announcement, the partnership is a critical component for the launch of MetAlert’s GunAlert(R) as well as the global rollout of its GPS SmartSole(TM) plus. TEAL will provide its advanced connectivity solutions and secure protocol for the GunAlert platform, an all-in-one gun safety combination lock with integrated motion sensor and GPS theft recovery technology, and the award-winning GPS SmartSole(TM), a wearable medical monitoring device that is integrated into an orthotic insole allowing discreet and unobtrusive tracking and remote monitoring of cognitively impaired individuals. TEAL’s patented, GSMA certified eSIM technology connects any compatible device onto any data network worldwide, providing the highest level of security and priority on local networks.

To view the full press release, visit https://ibn.fm/5nK34

About MetAlert Inc.

MetAlert is a pioneer in smart, mobile and wearable tracking and recovery location-based solutions, supported through a proprietary IOT enterprise monitoring platform and intellectual property portfolio. The company offers global end-to-end solutions of hardware, software and connectivity and develops two-way GPS tracking technologies, which seamlessly integrate with consumer products and enterprise applications, utilizing the latest in miniaturized, low power consumption GPS, cellular, RF, NFC, and BLE technology, enabling subscribers to track in real time the whereabouts of people or high value assets. MetAlert is known for its game-changing and award-winning patented GPS SmartSole – think Dr. Scholl’s meets LoJack, the world’s first visible wearable technology tracking device created for those at risk of wandering due to Alzheimer’s, dementia, autism and traumatic brain injury. MetAlert’s business model is built around technology innovation and the company holds dozens of patents, with many issued patents in the area of GPS tracking. The company has international distributors servicing customers across the globe with subscribers in over 40 countries and is a U.S. military government contractor. Other customers include public health authorities and municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes, and consumers. For more information, visit the company’s website at www.MetAlert.com.

NOTE TO INVESTORS: The latest news and updates relating to MLRT are available in the company’s newsroom at https://ibn.fm/MLRT

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

MiningNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Releases Q2, H1 2024 Financial Results Report

August 8, 2024 11:07:41

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, is reporting on its second-quarter and half-year 2024 results for the period ended June 30, 2024. The report showed stronger financial results, improved liquidity and capital resource, and steady gold and silver production.

The company will be hosting a conference call and webcast today to discuss the report. The call is slated to begin at 11 a.m. EDT. The call will also include time for questions and answers, with those on the call able to ask questions directly over the phone. Those wanting to participate can dial 888-210-3454 toll free in North American, then use conference ID number 3232920. An archived replay of the webcast will be available on the company’s website approximately two hours after the call ends.

“I’m delighted that this quarter was the most profitable since 2016 as measured by Adjusted EBITDA for our mining operations and Q3 is off to a good start,” said McEwen Mining chair and chief owner Rob McEwen in the press release. “Production costs increased 8% quarter-over-quarter, but revenue grew by 38%. Fox and Gold Bar are capitalizing on the higher gold prices to increase operating cash flow, Gold Bar in particular with its AISC at only $1,400 per GEO in H1.”

To view the webcast, visit https://ibn.fm/UkDa3

To view the full press release, visit https://ibn.fm/Q3jzw

About McEwen Mining Inc.

McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. The company also owns approximately 48% of McEwen Copper, which owns the large, advanced-stage Los Azules copper project in Argentina. The company’s objective is to improve the productivity and life of its assets with the goal of increasing the share price and providing investor yield. Rob McEwen, chair and chief owner, has a personal investment in the company of $225 million. His annual salary is $1. To learn more about the company, visit www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at https://ibn.fm/MUX

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

MiningNewsBreaks – Canada Nickel Company Inc.’s (TSX.V: CNC) (OTCQX: CNIKF) Reid Property Continues to Deliver ‘Excellent’ Assay Results

August 8, 2024 10:59:48

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF) today announced positive assay results for 13 holes from its ongoing 2024 exploration program at its Reid property. According to the announcement, all 34 holes drilled this year at Reid have intersected long intervals of targeted mineralized dunite and minor peridotite. Key highlights from the ongoing program include the best Reid interval to date, characterized by 661 meters of 0.29% nickel including 100 meters of 0.42% nickel and 40 meters of 0.51% nickel in REI-24-35. Additionally, all 8 holes targeting Reid Central Core intersected core lengths greater than 620 meters with average grades of 0.21% to 0.29% nickel.

“Reid continues to deliver excellent results, including the best individual hole to date with long core lengths grading in excess of 0.4% and 0.5% nickel and all holes delivering large intervals of target mineralization. With a target geophysical footprint larger than our flagship Crawford project and a width in the central core more than double Crawford, we look forward to the initial resource estimate for Reid expected to be released in the fourth quarter of 2024,” said Mark Selby, CEO of Canada Nickel.

To view the full press release, visit https://ibn.fm/N7zbR

About Canada Nickel Company Inc.

Canada Nickel is advancing the next generation of nickel- sulphide projects to deliver nickel required to feed the high-growth electric vehicle and stainless steel markets. Canada Nickel has applied in multiple jurisdictions to trademark the terms NetZero Nickel(TM), NetZero Cobalt(TM) and NetZero Iron(TM) and is pursuing the development of processes to allow the production of net-zero carbon nickel, cobalt and iron products. Canada Nickel provides investors with leverage to nickel in low political risk jurisdictions. Canada Nickel is currently anchored by its 100% owned flagship Crawford Nickel-Cobalt Sulphide Project in the heart of the prolific Timmins-Cochrane mining camp. For more information, please visit www.CanadaNickel.com.

NOTE TO INVESTORS: The latest news and updates relating to CNIKF are available in the company’s newsroom at https://ibn.fm/CNIKF

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

GreenEnergyBreaks — Exro Technologies Inc.’s (TSX: EXRO) (OTCQB: EXROF) Execs to Participate at This Month’s Canaccord Genuity 44th Annual Growth Conference

August 8, 2024 10:25:29

Exro Technologies (TSX: EXRO) (OTCQB: EXROF), a leading clean-technology company that provides proprietary motor-control and complete electric propulsion system technology for e-mobility, will be participating in the upcoming Canaccord Genuity 44th Annual Growth Conference. According to the announcement, the event will be held Aug. 13–15, 2024, in Boston. During the three-day conference, Exro CEO Sue Ozdemir and CFO Darrell Bishop are slated to lead a group presentation; the presentation is scheduled for Aug. 13. In addition, Ozdemir and Bishop will participate in one-on-one meetings with institutional investors and financial analysts throughout the gathering.

To view the full press release, visit https://ibn.fm/endBP

About Exro Technologies Inc.

Exro Technologies, now expanded through the strategic acquisition of SEA Electric, is a leading clean-technology company that has developed new-generation power control electronics. The company’s innovative suite of solutions, including Coil Driver(TM), Cell Driver(TM) and SEA-Drive(R), expand the capabilities of electric motors and batteries and offer original equipment manufacturer (“OEMs”) a comprehensive e-propulsion solution with unmatched performance and efficiency. Exro is reshaping global energy consumption, accelerating adoption toward a circular electrified economy by delivering more with less — minimum energy for maximum results. For more information about the company, please visit www.Exro.com.

NOTE TO INVESTORS: The latest news and updates relating to EXROF are available in the company’s newsroom at http://ibn.fm/EXROF

About GreenEnergyStocks

To receive SMS alerts from GreenEnergyStocks, text “Green” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenEnergyStocks.com

Please see full terms of use and disclaimers on the GreenEnergyStocks website applicable to all content provided by GES, wherever published or re-published: https://www.greennrgstocks.com/Disclaimer

GreenEnergyStocks
Los Angeles, CA
www.GreenEnergyStocks.com
310.299.1717 Office
[email protected]

GreenEnergyStocks is powered by IBN

CBDC Cruise Presents Crypto Blockchain Defi Conversations – Summit on the Seas

August 8, 2024 10:20:00

CBDC Cruises offers a once-in-a-lifetime experience with its ‘Summit on the Seas’ to C-level executives, professionals, enthusiasts, and members of the Crypto, DeFi, and Blockchain community. Attendees can enjoy top-notch amenities and a luxury experience as the cruise sets sail from Fort Lauderdale on November 16, 2024. Be a part of first-class networking, discussions, explorations, and collaborations as executives, enthusiasts, and families, all will sail aboard for the event.

Cabins and reservations are limited. Apart from business, education, and networking, attendees can relax and enjoy drinks and Round Robin dinners. The cruise offers world-class entertainment, visits to scenic ports, and, most importantly, an amicable environment to work and connect with like-minded…

To learn more, please visit https://cbdccruise.com

About CryptoCurrencyWire

To receive SMS alerts from CryptoCurrencyWire, text “CRYPTO” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CryptoCurrencyWire.com

CryptoCurrencyWire
New York, NY
www.CryptoCurrencyWire.com
212.994.9818 Office
[email protected]

CryptoCurrencyWire is powered by IBN

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Q2 2024 Financial, Operations Report

August 8, 2024 10:16:02

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, is reporting its financial results for second quarter 2024. Highlights of the report show that revenue for the quarter totaled $6.26 million, an 8.6% increase over Q1 2024 and a 1.7% over Q2 2023; Q2 commercial and consumer revenues came in at $7.34 million before a nonrecurring price concession in collaboration with a pharma partner, a 105% increase over Q2 2023; and core business-to-business-to-consumer (“B2B2C”) revenue channel, recurring revenues from employers and health plans in the second quarter, totaled $5.5 million, up 315% year over year and 60% sequentially from Q1 2024. The report also indicated that DarioHealth ended the quarter with cash equivalents of $22.9 million and anticipates reaching cash-flow breakeven by the end of 2025.

In addition, the report noted that during the quarter, DarioHealth made progress on collaboration with existing and potential pharma clients, saw strong business momentum on cross selling of its Twill offering to Dario clients with at least 10 initial clients, and executed on Dario-Twill synergies that expect to reduce operating expenses by approximately 40% by Q1 2025. In addition, Dario experienced increased GLP-1 product adoption with both new and existing clients seeking the company’s metabolic solutions.

“Looking ahead, we anticipate a significant reduction in operating losses over the next three quarters driven by continued revenue growth and aggressive cost-cutting measures implemented post-Twill merger,” said DarioHealth CEO Erez Raphael in the press release. “These cost-reduction initiatives, which commenced in early May 2024 and were completed in early August 2024 , are expected to yield a 24% decrease in GAAP operating expenses and a 40% decrease in non-GAAP operating expenses from the first quarter of 2024 to the first quarter of 2025. Additionally, we expect gross margins to climb to 80% by the first quarter of 2025, as our core B2B2C revenues have already reached 82% gross margins in the second quarter. These combined efforts are anticipated to result in a 58% reduction in GAAP operating loss and 75% reduction in non-GAAP operating losses between the first quarter of 2024 and the first quarter of 2025, providing a clear path to cash flow breakeven by the end of 2025.”

To view the full press release, visit https://ibn.fm/ksax2

About DarioHealth Corp.

DarioHealth Corp. is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic-condition, digital-therapeutics platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. The company’s user-centric platform offers people continuous and customized care for their health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results, making the right thing to do the easy thing to do. Dario provides its highly user-rated solutions globally to health plans and other payors, self-insured employers and providers of care as well as directly to consumers. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

CannaCon Midwest Cleveland Convention To Focus On The Local Community

August 8, 2024 09:35:00

Cannabis growers, traders, license holders, physicians, patients, regulatory authorities, capital investors, professionals, and enthusiasts are invited to attend the CannaCon Cleveland Conference at the Huntington Convention Center, Cleveland, on October 3-4, 2024. The venue of the event, the Huntington Convention Center is situated in the heart of downtown Cleveland, near the legendary Rock & Roll Hall of Fame and the International Women’s Air & Space Museum, among others.

The CannaCon event offers a robust platform for the local cannabis community, with two full days of innovation, learning, networking, and collaboration. Exhibitors from around the world will be pitching their latest products and services to a crowd of established investors and business experts in the…

To learn more, please visit https://cnw.fm/YoTB3

About CannabisNewsWire

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

NECANN’s Michigan Cannabis Convention Offers Unique Business Ideas for Cannabis Sector

August 8, 2024 08:50:00

Businesses, entrepreneurs, investors, educators, patients, advocates, and consumers are invited to attend the NECANN Michigan Cannabis Convention on September 20-21, 2024, in Grand Rapids. NECANN events are organized to meet the needs and provide collaborative opportunities for the local cannabis community. One of the biggest cannabis conventions in the country, NECANN events witness some of the most eminent dignitaries of the cannabis spectrum gracing the event floor.

Instead of hosting generic cannabis conventions, NECANN took a customized approach. As every region has its challenges, NECANN understands the specific requirements relevant to the area. They collaborate with local traders, growers, investors, sponsors, and industries, so that the regional cannabis community…

To know more, please visit https://cnw.fm/b1Vp1

About CannabisNewsWire

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

Lexaria Bioscience Corp. (NASDAQ: LEXX) Exploring Alternative Diabetes and Obesity Treatments

August 8, 2024 08:05:00

Lexaria, a global innovator in drug delivery platforms, is exploring alternatives to traditional diabetes and obesity management through its patented DehydraTECH(TM) technology to potentially enhance oral ingestion vs. injection treatment of GLP-1 drugs
The company has made significant strides pairing their bioavailability enhancing DehydraTECH with glucagon-like peptide-1 (“GLP-1”) drugs used for treatment of diabetes and obesity
Projections are that by 2030 over 54.9 of Americans could have diabetes, and that by 2045 one in eight adults globally will be living with the condition

According to the International Diabetes Federation Diabetes Atlas of 2021, 10.5% of adults aged between 20 and 79 globally have diabetes. In addition, almost half of them are unaware that they are living with the condition. The Federation further projects that by 2045, one in eight adults in the world will be living with diabetes. This will represent approximately 783 million people, an increase of 46% from the current numbers (https://cnw.fm/QsqcW).

The figures in the United States are just as startling, with 38.4 million people of all ages, or 11.6% of the country’s population having diabetes, according to the Centers for Disease Control (“CDC”) (https://cnw.fm/dHQHL). Also, a Population Health Management report shows estimates that, by…

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

420 with CNW — Legalizing Medical Cannabis in North Carolina Still Faces Huge Hurdles

August 7, 2024 15:25:00

For the third year in a row, the senate of North Carolina approved the Compassionate Care Act. The measure aims to allow the sale of marijuana and marijuana-infused products to patients who qualify under a set of strict conditions, utilizing a regulated medical marijuana system. Despite this progress, the legislation is presently stuck in the house.

Adding to the complexity, a recent decision by the Supreme Court has influenced the discussion around reclassifying marijuana as a…

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

TinyGemsBreaks – Pineapple Financial Inc. (NYSE American: PAPL) Spotlighted in RazorPitch Article Highlighting Tremendous Growth Opportunities in Canada’s Unique Mortgage Market

August 7, 2024 14:55:55

Pineapple Financial (NYSE American: PAPL), a digital mortgage company focused on providing Canadian mortgage brokers with the systems, tools, and technologies they need to provide home buyers and mortgage seekers with a more digital customer experience, has been featured in a RazorPitch article. With Canada’s unique mortgage market requiring holders to refinance after every five years, Pineapple Financial offers investors the perfect way to capitalize on this opportunity. According to the article, the company’s technology is designed and geared towards Canadian mortgage brokers, a very fast-growing channel of origination.

Over 75% of half of all mortgages that Canadians are first-time home buyers; also, more than 70% of buyers under the age of 45 prefer to utilize a mortgage broker. The article expects these growing demographics to prefer using digital channels such as Pineapple’s platform, which is reaffirmed when other areas of the world are considered. “For instance, in Australia, Europe, and the U.S., over 80% of mortgage originations are done through the mortgage broker channel. This means that Pineapple has plenty of room to grow as the market organically grows in Canada. To put the opportunity in context, consider this: There is about $2.2 trillion of outstanding mortgage debt in Canada,” the article reads.

Additionally, Canada’s mortgage terms, which span 1 to 5 years, provide Pineapple with the opportunity to reservice customers, with these continual servicing opportunities providing the company with tremendous potential to continue growing revenue and the business. The article noted that 73% of all current Canadian mortgages will be coming up for maturity within the next three years or by the end of 2027, translating to about $1.6 trillion of potential origination. In addition to that, Canada has the fastest-growing population in the world, which, coupled with about 4 million Canadians entering the home buying stage of their lives, means that Pineapple Financial has a tremendous growth opportunity.

To view the full article, visit https://ibn.fm/3J6Fb

About Pineapple Financial Inc.

Pineapple Financial is an award-winning fintech and leading Canadian mortgage brokerage network. It focuses on the long-term success of agents and brokers and the overall experience of homeowners. With hundreds of brokers within the network, Pineapple Financial creates cutting-edge tools and AI-driven systems to enable its brokers to help Canadians realize their dream of owning a home. The company is active within the community and is proud to sponsor charities across Canada to improve the lives of fellow Canadians. For more information about the company, visit www.gopineapple.com.

About TinyGems

To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems
Los Angeles, CA
www.TinyGems.com
310.299.1717 Office
[email protected]

TinyGems is powered by IBN

TechMediaBreaks – Match Group Inc. (NASDAQ: MTCH) Quarterly Earnings Report Highlights

August 7, 2024 14:44:11

Match Group (NASDAQ: MTCH), a leading company in the internet commerce industry, recently reported its quarterly earnings, aligning with the Zacks Consensus Estimate at $0.48 per share, mirroring its performance from the previous year. The company’s revenue for the quarter ending June 2024 was $864.07 million, slightly up from the previous year’s $829.55 million, and exceeded the Zacks Consensus Estimate by 0.92%. This achievement marks the fourth consecutive quarter where Match Group has surpassed consensus revenue estimates, showcasing its consistent performance in a competitive market.

Despite these positive earnings reports, Match Group’s stock has seen a decline of about 9% since the start of the year, underperforming when compared to the S&P 500’s gain of 14.5%. This decline in stock performance, despite the company’s solid revenue growth, highlights the challenges Match Group faces in the stock market. The company’s future stock performance is now under scrutiny, especially with an earnings outlook and recent trend in earnings estimate revisions suggesting a Zacks Rank #4 (Sell), indicating potential underperformance in the near term.

Looking forward, Match Group is expected to achieve an EPS of $0.57 in the next quarter on revenues of $913.68 million, with the full year’s consensus earnings per share projected at $2.11 on $3.55 billion in revenues. These projections are critical for investors as they evaluate the company’s potential for growth amidst the broader internet commerce industry’s performance, which is ranked in the top 25% of over 250 Zacks industries.

On the trading front, Match Group’s stock saw a slight increase of $0.14, or approximately 0.39%, reflecting the volatile nature of the stock market. The stock’s trading range between $35.1 and $36.01 on the day of the report, along with its fluctuation over the past year from a low of $27.655 to a high of $47.81, underscores the stock’s volatility and the broader market’s fluctuating confidence in the internet commerce sector. With a market capitalization of roughly $9.23 billion and a trading volume of 1,058,830 shares, Match Group remains a significant player in its industry, despite the challenges it faces in enhancing shareholder value and navigating market expectations.

To view the company’s latest earnings release, visit https://ibn.fm/iZdbA

About Match Group

Match Group, through its portfolio companies, is a leading provider of digital technologies designed to help people make meaningful connections. Its global portfolio of brands includes Tinder(R), Hinge(R), Match(R), Meetic(R), OkCupid(R), Pairs(TM), PlentyOfFish(R), Azar(R), BLK(R), and more, each built to increase its users’ likelihood of connecting with others. Through the company’s trusted brands, it provides tailored services to meet the varying preferences of its users. Match Group’s services are available in over 40 languages to users all over the world.

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
[email protected]

TechMediaWire is powered by IBN

BioMedNewsBreaks — Scorpius Holdings Inc. (NYSE American: SCPX) Releases Public Offering Pricing for Public Offering

August 7, 2024 14:32:38

Scorpius Holdings (NYSE American: SCPX), an integrated contract-development and manufacturing organization (CDMO), has announced the pricing of an underwritten public offering. The offering is comprised of 12,500,000 shares of common stock or prefunded warrants. Each share of common stock or prefunded warrant is offered at $1. According to the announcement, the company has estimated gross proceeds of approximately $12,500,000, before underwriting discounts and offering expenses are deducted; the proceeds will be used for working capital and general corporate expenses. The company also granted the underwriters a 45-day option to purchase up to 1,875,000 additional shares of common stock and/or prefunded warrants to cover any overallotments. ThinkEquity is acting as sole book-running manager for the offering.

To view the full press release, visit https://ibn.fm/mO9sY

About Scorpius Holdings Inc.

Scorpius Holdings is an integrated large-molecule contract-development and manufacturing organization (“CDMO”) focused on rapidly advancing biologic and cell-therapy programs to the clinic and beyond. Scorpius offers a broad array of analytical testing, process development and manufacturing services to pharmaceutical and biotech companies at its state-of-the-art facilities in San Antonio, Texas. With an experienced team and new, purpose-built U.S. facilities, Scorpius is dedicated to transparent collaboration and flexible, high-quality biologics biomanufacturing. For more information about the company, please visit www.ScorpiusBiologics.com.

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Subsidiary Submits Proposal to CDMRP for Ovarian Cancer Detection Research Award

August 7, 2024 14:24:44

Aditxt (NASDAQ: ADTX), a company dedicated to discovering, developing and deploying promising health innovations, and its subsidiary, Pearsanta Inc., has submitted a proposal for the Clinical Trial Translational Endpoints Research Award to the Congressionally Directed Medical Research Programs (“CDMRP”) of the Department of Defense. According to the announcement, the proposal is designed to validate a novel assay based on Pearsanta’s proprietary Mitomic(R) technology designed for the early detection of ovarian cancer.

“We believe the clinical impact of Pearsanta’s Mitomic Ovarian Test could be profound,” said Aditxt cofounder, chair and CEO Amro Albanna in the press release. “If we are successful in facilitating earlier detection and more effective treatment interventions through a simple blood test, we believe that we can significantly improve survival rates for women with ovarian cancer, addressing a critical unmet need in women’s health. Despite the high incidence and mortality rates, we are not aware that any blood tests are currently available with adequate sensitivity for early ovarian cancer detection. Our acceleration of Pearsanta’s innovations seeks to address a critical unmet need in women’s health and can potentially save many lives.”

To view the full press release, visit https://ibn.fm/p1KF3

About Aditxt Inc.

NOTE TO INVESTORS: The latest news and updates relating to ADTX are available in the company’s newsroom at https://ibn.fm/ADTX

About TinyGems

To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems
Los Angeles, CA
www.TinyGems.com
310.299.1717 Office
[email protected]

TinyGems is powered by IBN

TechMediaBreaks – SideChannel Inc. (SDCH) Releases Quarterly Report, Notes Second Consecutive Quarter of Positive Cash Flow

August 7, 2024 13:28:49

SideChannel (OTCQB: SDCH), a leading provider of cybersecurity services and technology to emerging and middle market companies, is reporting its financial results for the three- and nine-month period ended June 30, 2024. Highlights of the report include third-quarter revenue of $1.8 million, year-to-date revenue of $5.5 million, and third-quarter gross margin of 48.9%. The report also showed a decrease in third-quarter operating expenses. In addition, the report indicated revenue retention of 72.3% for the trailing 12 months ended June 30, 2024, with an ending cash balance of $1.1 million at quarter end.

The company will be holding a conference call and webcast today at 4:30 p.m. ET to discuss the report results and to provide an update on the company’s initiatives; the call will also include time for questions and answers. Individuals wanting to access the call can dial 888-506-0062 (toll free) or 973-528-0011 (international), then use the access code 756675.

“This is our second consecutive quarter of positive cash flow from operations,” said SideChannel president and CEO Brian Haugli in the press release. “The expense reductions we implemented over one year ago, combined with our consistent revenue growth have put us in positive cash flow territory. We have begun using a portion of our quarterly cash flow to fund investments in our sales and marketing team, including additional emphasis on Enclave. We are eager to communicate how our novel approach to microsegmentation is proving to be a significantly cost-effective alternative to using hardware.”

To view the webcast, visit https://ibn.fm/1CEML

To view the full article, visit https://ibn.fm/wEVR2

About SideChannel Inc.

SideChannel helps emerging and mid-market companies protect their assets. Founded in 2019, the company delivers comprehensive cybersecurity plans through a series of actions branded SideChannel Complete. SideChannel deploys a combination of skilled and experienced talent along with technological tools to offer layered defense strategies supported by battle-tested processes. SideChannel also offers Enclave, a network infrastructure platform that eases the journey from zero to zero-trust. For more information about the company, please visit www.SideChannel.com.

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
[email protected]

TechMediaWire is powered by IBN

TechMediaBreaks – Iteris Inc. (NASDAQ: ITI) Selected by City of Lakeland to Enhance Road User Safety, Security

August 7, 2024 13:05:28

Iteris (NASDAQ: ITI), the world’s trusted technology ecosystem for smart mobility infrastructure management, today announced that the City of Lakeland, Florida, has selected it to provide smart mobility infrastructure management technologies to support the city’s Intersection Crash Avoidance Safety Program (“iCASP”). The project includes the deployment of key components of Iteris’ ClearMobility(R) Platform, the world’s most complete solution to monitor, visualize and optimize mobility infrastructure continuously.

According to the announcement, the City of Lakeland initiated this project because of the many crashes attributed to red light running in certain high-impact intersections throughout the city. Therefore, the deployment of Iteris’ advanced technology at 19 of these intersections is expected to enhance security for the traveling public in the city.

“We’re thrilled to be supporting FDOT and the City of Lakeland in their Intersection Collision Avoidance Safety Program,” commented Kevin Exner, regional vice president at Iteris. “This is not only an excellent chance to carry on with our extensive work in the Florida market, but it also combines two of our greatest passions at Iteris: the advancement of ITS infrastructure and the enhancement of road user safety.”

To view the full press release, visit https://ibn.fm/qIQKR

About Iteris Inc.

Iteris is the world’s trusted technology ecosystem for smart mobility infrastructure management. Delivered through its ClearMobility(R) Platform, the company’s AI-powered end-to-end solutions monitor, visualize and optimize mobility infrastructure around the world, and help bridge legacy technology silos to unlock the future of transportations. That’s why more than 10,000 public agencies and private-sector enterprises focused on mobility rely on Iteris every day. For more information about the company, visit www.iteris.com.

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
[email protected]

TechMediaWire is powered by IBN

TechMediaBreaks – Nature’s Miracle Holding Inc. (NASDAQ: NMHI) Closes on Public Offering Valued at $1.2M

August 7, 2024 12:37:56

Nature’s Miracle (NASDAQ: NMHI), a growing agriculture-technology company providing equipment and services to growers in the controlled environment agriculture (“CEA”) industry, has closed on its previously announced underwritten public offering. The offering was comprised of five million shares of common stock at a public offering price of $0.24 per share. The offering resulted in gross proceeds of $1.2 million, before underwriting discounts and offering expenses were deducted. The underwriter was also granted an option to purchase additional common stock shares of the company and/or warrants. EF Hutton LLC acted as the sole book running manager for the offering.

To view the full press release, visit https://ibn.fm/TzuWG

About Nature’s Miracle Holding Inc.

Nature’s Miracle is a growing agriculture technology company providing equipment and services to growers in the controlled environment agriculture (“CEA”) industry, which also includes vertical farming in North America. Nature’s Miracle offers hardware to design, build and operate various indoor growing settings including greenhouses and indoor-growing spaces. Nature’s Miracle, through its two wholly owned subsidiaries (Visiontech Group Inc. and Hydroman Inc.), provides grow lights as well as other hydroponic products to hundreds of indoor growers in North America. For more information about this company, visit www.Nature-Miracle.com.

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
[email protected]

TechMediaWire is powered by IBN

GreenEnergyBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Promotes ‘Invaluable Asset’ to Position of President of Commercial EV Division

August 7, 2024 12:10:59

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced John Taylor as president of its commercial EV division. In his new role, Taylor will oversee the company’s commercial vehicle operations, including engineering, supply chain management and manufacturing. Taylor, who brings a great breath of experience with a career spanning more than 35 years, also retains his role as senior vice president of global manufacturing for Mullen Automotive. He joined Mullen in 2021 and has played a pivotal role in the development and successful launch of the Mullen ONE Class 1 EV cargo van and Mullen THREE Class 3 low cab forward commercial EV lines which launched in September and November 2023. “John has been an invaluable asset to our company and his promotion to president of Commercial EV division is a testament to his exceptional leadership and contributions,” commented David Michery, CEO and chairman of Mullen Automotive. “His proven expertise will be instrumental in driving growth, expanding our market share and achieving our commercial EV business goals.”

To view the full press release, visit https://ibn.fm/bQkbj

About Mullen Automotive Inc.

NOTE TO INVESTORS: The latest news and updates relating to MULN are available in the company’s newsroom at https://ibn.fm/MULN

About GreenEnergyStocks

To receive SMS alerts from GreenEnergyStocks, text “Green” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenEnergyStocks.com

Please see full terms of use and disclaimers on the GreenEnergyStocks website applicable to all content provided by GES, wherever published or re-published: https://www.greennrgstocks.com/Disclaimer

GreenEnergyStocks
Los Angeles, CA
www.GreenEnergyStocks.com
310.299.1717 Office
[email protected]

GreenEnergyStocks is powered by IBN

InvestorNewsBreaks – Freight Technologies Inc.’s (NASDAQ: FRGT) Fr8App Integrates with Tecnomotum to Streamline Logistics Operations

August 7, 2024 12:05:00

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), an innovative logistics technology solutions company, today announced the integration of its custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine learning that offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region, with Tecnomotum, one of the largest data transmission companies for haulage in Mexico. According to the announcement, this integration aims to maximize savings, enhance user experience, provide real-time data, improve fleet connectivity and efficiency, and streamline logistics operations.

“We are proud to offer our customers an even better and more seamless experience. Fr8App’s commitment to collaborating with key players in the logistics industry is unparalleled. With each new integration, Fr8App solidifies its position as the most connected and integrable platform for cross-border shipping in the USMCA region. By continuing to partner with industry leaders, Fr8App is leading the way in simplifying logistics processes and enhancing visibility for customers. Our dedication to integration underscores our commitment to delivering the best possible service to customers and is a testament to our continued success in the logistics industry,” commented Javier Selgas, CEO of Fr8Tech.

To view the full press release, visit https://ibn.fm/DD4bM

About Freight Technologies Inc.

NOTE TO INVESTORS: The latest news and updates relating to FRGT are available in the company’s newsroom at https://ibn.fm/FRGT

Corporate Communications
IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

MiningNewsBreaks – Independence Contract Drilling Inc. (NYSE: ICD) Releases Q2 2024 Financial Results

August 7, 2024 11:49:18

Independence Contract Drilling (NYSE: ICD), a company that provides land-based contract drilling services for oil and natural-gas producers in the United States, is reporting its Q2 2024 financial results for the three-month period ended June 30, 2024. Notable numbers from the report include a net loss of $16.7 million, or $1.15 per share, with adjusted net loss of $10.6 million, or $0.73 per share. Adjusted EBITDA totaled $8.5 million, representing a 28% sequential decrease, with adjusted net debt of $196.7 million, which was a 3% sequential increase. The company also reported that 14.5 average rigs working during the quarter, which was a 4% sequential decrease, with a fully burdened margin per day of $9,675, representing a 18% sequential decrease.

“Our financial results for the second quarter came in line with our expectations, as the overall U.S. land contract drilling market continued to be impacted by elevated rig churn from headwinds driven by customer consolidation, accelerating drilling efficiencies and increased fiscal discipline by E&P customers,” said Independence Contract Drilling CEO Anthony Gallegos in the press release. “These headwinds have continued into the third quarter of 2024 and resulted in the delay or cancellation of expected third-quarter rig reactivation opportunities and additional rig releases where our rigs will be required to be placed with new customers. . . . Assuming our re-contracting efforts are successful, we expect our operating rig count will return to second quarter levels by the end of the fourth quarter of 2024.”

To view the full press release, visit https://ibn.fm/QlX30

About Independence Contract Drilling Inc.

Independence Contract Drilling provides land-based contract drilling services for oil and natural gas producers in the United States. The company constructs, owns and operates a fleet of pad-optimal ShaleDriller rigs that are specifically engineered and designed to accelerate its clients’ production profiles and cash flows from their most technically demanding and economically impactful oil and gas properties. For more information, visit www.ICDrilling.com.

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Releases Q2 2024 Financial Results, Provides Updates

August 7, 2024 11:36:15

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), today released its Q2 2024 financial results. In addition, the company provided recent updates on its CNM-Au8(R) programs evaluating the use of CNM-Au8 for the treatment of ALS and Rett Syndrome. “We are approaching our next FDA interaction focused on the regulatory path forward to potentially bring CNM-Au8 to people living with ALS,” commented Rob Etherington, President and CEO of Clene. “With this imminent timing, we are optimistic about the possibility of submitting a new drug application later this year. Our utmost priority is to help patients and their families for whom time is critical.”

To view the full press release, visit https://ibn.fm/hELDe

About Clene Inc.

Clene (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease and multiple sclerosis. CNM-Au8(R) is an investigational first-in-class therapy that improves central nervous system cells’ survival and function via a mechanism that targets mitochondrial function and the NAD pathway while reducing oxidative stress. CNM-Au8(R) is a federally registered trademark of Clene Nanomedicine, Inc. The company is based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland. For more information, please visit www.Clene.com.

NOTE TO INVESTORS: The latest news and updates relating to CLNN are available in the company’s newsroom at https://ibn.fm/CLNN

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

TechMediaBreaks – Trump Media & Technology Group (NASDAQ: DJT) Announces ‘Milestone’ Launch of TV Streaming on iOS Devices

August 7, 2024 11:23:05

Trump Media & Technology Group (NASDAQ: DJT), operator of the social-media platform Truth Social, has added linear TV streaming functionality on iOS devices. According to the announcement, iOS users can update their Truth Social apps through the Apple App Store to access TV streaming. After the app has been updated, they can use the new feature by clicking on the Truth+ streaming icon, which looks like a TV and which enables users to stream content as standalone channels or in a separate picture-in-picture (“PiP”) window while on the Truth Social platform.

The addition of streaming on iOS devices is a piece of TMTG’s strategic rollout of its streaming platform: Truth+. Next, the company anticipates releasing streaming apps integrated with the Truth Social platform that will offer features such as an interactive 14-day electronic guide, instant catch-up TV on shows broadcast in the past week, network DVR, video on demand, subscription video on demand, a marketplace and more.

“We’ve hit a big milestone in our TV streaming rollout, with the service now available across the entire Truth Social platform — iOS, Android and the Web,” said Trump Media & Technology Group CEO Devin Nunes in the press release. “Our uncancellable CDN is delivering high-quality TV streaming to all Truth Social users. As we continue to test the service, we look forward to rolling out new Truth+ apps for over-the-top streaming to mobile devices and TVs.”

To view the full press release, visit https://ibn.fm/I74fl

About Trump Media & Technology Group

Trump Media & Technology Group is on a mission to end Big Tech’s assault on free speech by opening up the internet and giving people their voices back. TMTG operates Truth Social, a social media platform established as a safe harbor for free expression amid increasingly harsh censorship by Big Tech corporations. For more information about this company, visit www.TMTGCorp.com.

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
[email protected]

TechMediaWire is powered by IBN

InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Enters Agreement to Launch New Study of SPU-16 Homing Peptide for Multiple Sclerosis

August 7, 2024 11:05:00

Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company focused on developing novel formulations and drug-delivery systems for traditional therapeutics and psychedelic treatments, has entered into an agreement with WuXi AppTec (Hong Kong) Limited, a leading global contract research organization (“CRO”). The agreement regards the launch of a preclinical small animal study of SPU-16, a central nervous system (“CNS”) homing peptide targeting multiple sclerosis (“MS”). According to the announcement, Silo Pharma is advancing SPU-16 development through a commercial evaluation license and option agreement with the University of Maryland, Baltimore (“UMB”).

“We are excited to launch this new study of our novel CNS homing peptide under the management of WuXi AppTec, one of the largest CROs in Asia and globally,” said Silo CEO Eric Weisblum. “Designed to cross the blood-brain barrier and target damaged tissue and inflammation, SPU-16 has been shown to enhance the therapeutic effect of current and future therapeutics while decreasing the toxicity of the drugs. While we are currently investigating the peptide for MS, it could provide similar benefits for multiple neuroinflammatory pathologies.”

To view the full press release, visit https://ibn.fm/3T0fu

About Silo Pharma Inc.

Silo Pharma is a developmental-stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions and central nervous system (“CNS”) diseases. Silo focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug-delivery systems. The company’s lead program, SPC-15, is an intranasal treatment targeting post-traumatic stress disorder (“PTSD”) and stress-induced anxiety disorders. SP-26 is a time-release, ketamine-loaded implant for fibromyalgia and chronic pain relief. Silo’s two preclinical programs are SPC-14, an intranasal compound for the treatment of Alzheimer’s disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (“MS”). Silo’s research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. For more information about the company, visit http://www.silopharma.com/.

NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Studies Explore Changing Wastewater into Fertilizer

August 7, 2024 10:05:00

New studies are exploring whether using organic waste to make fertilizers could help promote sustainable production and decrease fossil fuel consumption. One of the studies, by the University of Illinois Urbana-Champaign, focused on using a fungal treatment to make fertilizer from leftover wastewater for agricultural crops.

The researchers were using a process known as hydrothermal liquefaction (HTL), which makes biocrude oil from biomass via a…

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

Snycio, Vevol Media Partner to Transform eCommerce Store Management

August 7, 2024 10:05:00

Recently, Syncio entered into a partnership agreement with Vevol Media to streamline e-commerce operations for businesses by integrating different sales channels. Syncio has, for a while now, been streamlining e-commerce operations for merchants on WooCommerce and Shopify. The company is focused on efficiency and simplicity, while Vevol Media specializes in assisting businesses to thrive in the digital marketplace.

Vevol, a leading partner of Shopify, provides a…

NOTE TO INVESTORS: The latest news and updates relating to NextPlat Corp. (NASDAQ: NXPL, NXPLW) are available in the company’s newsroom at https://ibn.fm/NXPL

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

Missouri Bans Sale of Delta-8 Intoxicants

August 7, 2024 10:05:00

The state of Missouri has placed a ban on the sale of candy, beverages and other edible products manufactured from intoxicating substances derived from hemp. Missouri is not the only state to regulate and/or impose a ban on delta-8 THC, with the move coming after the state’s governor Mike Parson issued an executive order on the same last week.

The ban is set to go into effect from…

About CannabisNewsWire

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

Uber, BYD to Put 100K EVs on Roads in Major Markets, Excluding the US

August 7, 2024 10:05:00

Chinese automotive giant BYD and American ride-hailing service Uber have revealed that they are teaming up to put a whopping 100,000 battery electric vehicles on roads in major markets outside the United States. A recent Bloomberg report noted BYD is set to provide Uber with tens of thousands of electric cars to run under its ride-hailing service in Canada, Europe, the Middle East, Latin America, New Zealand and Australia, with lower vehicle financing and pricing for drivers.

The United States, currently one of the largest electric-vehicle markets in the world, was conspicuously absent from Uber and…

About GreenCarStocks

To receive SMS alerts from GreenCarStocks, text “Green” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the GreenCarStocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

GreenCarStocks
Los Angeles, CA
www.GreenCarStocks.com
310.299.1717 Office
[email protected]

GreenCarStocks is powered by IBN

How ESG Reporting is Significant in Corporate Strategy

August 7, 2024 10:05:00

Reporting on environmental, social and governance (ESG) standards in this day and age is important. It encourages accountability and corporate transparency, while also assisting companies in improving resource efficiency.

ESG reporting also highlights cost-cutting opportunities and areas for improvement. This is in addition to enabling shareholders to…

NOTE TO INVESTORS: The latest news and updates relating to First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) are available in the company’s newsroom at https://ibn.fm/FSTTF

About ESGWireNews

To receive SMS alerts from ESGWireNews, text “ESG” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.ESGWireNews.com

Please see full terms of use and disclaimers on the ESGWireNews website applicable to all content provided by ESG, wherever published or re-published: https://www.ESGWireNews.com/Disclaimer

ESGWireNews
Los Angeles, CA
www.ESGWireNews.com
310.299.1717 Office
[email protected]

ESGWireNews is powered by IBN

US Courts Face Puzzle as Music Labels Sue Over AI

August 7, 2024 10:05:00

Udio, an artificial intelligence (AI) music website, seems to be imitating songs written and produced by actual people, flouting the rights of artists globally. This shows how music generated by artificial intelligence is not based on its own creativity but rather by “stealing” the labor and creativity of others.

This explains why earlier this year, artists such as Stevie Wonder, Nicki Minaj, Billie Eilish and Tift Merritt, among others, penned a letter warning that…

About AINewsWire

AINW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from AINewsWire, text “AI” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit www.AINewsWire.com

Please see full terms of use and disclaimers on the AINewsWire website applicable to all content provided by AINW, wherever published or re-published: https://www.AINewsWire.com/Disclaimer

AINewsWire
Los Angeles, CA
www.AINewsWire.com
310.299.1717 Office
[email protected]

AINewsWire is powered by IBN

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO to Participate in a Fireside Chat at Upcoming Conference

August 7, 2024 09:55:00

Cybin (NYSE American: CYBN) (Cboe CA: CYBN), a clinical-stage biopharmaceutical company developing new and innovative next-generation psychedelic-based treatment options, today announced that its CEO, Doug Drysdale, will participate in a fireside chat at the Canaccord Genuity 44th Annual Growth Conference on Tuesday, August 13, 2024, at 2 p.m. ET. Mr. Drysdale’s fireside chat will be a live webcast. The archived webcast will be available on Cybin’s investor relations website on the Events & Presentations page.

To access the live webcast, visit https://ibn.fm/i1idM

To view the full press release, visit https://ibn.fm/vSRdp

About Cybin Inc.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Release Promising Clinical Data As Global Alzheimer’s Disease Therapeutics Market Grows

August 7, 2024 09:48:35

Annovis Bio (NYSE: ANVS), a late-stage, clinical-drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), has released preclinical data from a study of its lead compound, buntanetap. According to the announcement, the study showed the synergistic effect of buntanetap combined with the glucagon-like peptide 1 (GLP-1) agonist dulaglutide (Trulicity[R]) in enhancing cognition in a mouse model of Alzheimer’s disease.

The news comes as the global Alzheimer’s Disease Therapeutics Market is experiencing significant growth as an escalating aging population along with earlier and more accurate diagnoses contribute to more people facing the disease. The article noted that the sector is projected to exceed $30.8 billion by 2033, with a promising CAGR of 18.8% from 2024 to 2033. Biotech and pharma companies active in the space include Pfizer Inc. (NYSE: PFE), Eli Lilly and Company (NYSE: LLY), GSK plc (NYSE: GSK) and Novo Nordisk A/S (NYSE: NVO).

To view the full press release, visit https://ibn.fm/joKbE

About Annovis Bio Inc.

For more information, visit the company’s website at www.AnnovisBio.com, and social channels LinkedIn, X and YouTube.

NOTE TO INVESTORS: The latest news and updates relating to ANVS are available in the company’s newsroom at https://ibn.fm/ANVS

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

TechMediaBreaks – Bebuzee Inc. (BBUZ) Announces ‘Milestone’ Launch of SuperApp Designed to Change Users’ Interaction with Digital Services

August 7, 2024 09:37:00

Bebuzee (OTC: BBUZ), a pioneering force in the realm of social technology, has unveiled a new SuperApp designed to transform the way users interact with technology. According to the announcement, the new app, which will be available Aug. 30, 2024, offers an extensive array of features in a single, seamless platform. Those features include video streaming, photo sharing, instant messaging, short-form videos, global real estate search and e-commerce capabilities.

The company noted that the new app opens unprecedented revenue opportunities. With potential in a wide array of markets, including video ads, sponsored posts, premium subscriptions and more, the app will support Bebuzee’s efforts to capture significant market share.

“We are incredibly excited to launch Bebuzee’s SuperApp, a platform that will change the way users interact with digital services,” said Bebuzee CEO Joe Onyero in the press release. “This launch is not just a milestone for Bebuzee, but a leap forward in the tech industry, promising substantial returns for our investors.”

To view the full press release, visit https://ibn.fm/TdxmB

About Bebuzee Inc.

Bebuzee is a leading social media and digital entertainment platform dedicated to providing innovative and engaging experiences for its users. With a focus on community-driven content and seamless integration of diverse digital services, Bebuzee is at the forefront of the next generation of social media platforms. For more information about the company, please visit www.Bebuzee.com.

NOTE TO INVESTORS: The latest news and updates relating to BBUZ are available in the company’s newsroom at https://ibn.fm/BBUZ

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
[email protected]

TechMediaWire is powered by IBN

AINewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Schedules Release of Q2 2024 Financial Results, Conference Call

August 7, 2024 09:32:54

Predictive Oncology (NASDAQ: POAI) is a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (“CLIA”) laboratory and Good Manufacturing Practices (“GMP”) to accelerate oncology drug discovery and enable drug development. The company expects to report its financial results for the second quarter of fiscal 2024, ended June 30, 2024, before markets open on Wednesday, August 14, 2024. Additionally, Predictive Oncology will host a corporate update conference call and live audio webcast that same day at 8:30 a.m. ET. Interested parties can dial 877-407-3982 (toll free) or 201-493-6780 (international) and enter the conference ID 13748154.

To view the live webcast, visit https://ibn.fm/nHxb0

To view the full press release, visit https://ibn.fm/DWjc5

About Predictive Oncology Inc.

Predictive Oncology is on the cutting edge of the rapidly growing use of artificial intelligence (“AI”) and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy if a tumor sample will respond to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. With the company’s vast biobank of more than 150,000 assay-capable heterogenous human tumor samples, Predictive Oncology offers its academic and industry partners one of the industry’s broadest AI-based, drug-discovery solutions, further complemented by its wholly owned Clinical Laboratory Improvement Amendments (“CLIA”) lab and GMP facilities. For more information about the company, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About AINewsWire

AINW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from AINewsWire, text “AI” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit www.AINewsWire.com

Please see full terms of use and disclaimers on the AINewsWire website applicable to all content provided by AINW, wherever published or re-published: https://www.AINewsWire.com/Disclaimer

AINewsWire
Los Angeles, CA
www.AINewsWire.com
310.299.1717 Office
[email protected]

AINewsWire is powered by IBN

FinovateFall New York 2024 Invites the Global Fintech Community

August 7, 2024 08:50:00

The FinovateFall 2024 event, held from September 9-11, 2024, at the Marriott Marquis Times Square, New York, offers the premiere interactive business platform, for industry experts, startups, and unicorns, to stage demos and showcase innovative ideas.

FinovateFall New York will witness 2,000+ attendees interacting with peers and industry leaders on the event floor, with over 1,000 bank and financial institution representatives, and with 1,400+ attendees being top executives, directors, and VPs. Directly connected to the exhibition floor, the event features…

To know more, please visit https://ibn.fm/5x9bn

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Nikola Corp., ITD Industries Launch Hydrogen Refueling Station in Ontario

August 7, 2024 08:05:00

Nikola Corporation (NASDAQ: NKLA), known for developing heavy-duty commercial vehicles with zero emissions, has partnered with ITD Industries, a leader in industrial solutions, to launch a new hydrogen refueling station in Ontario. The launch shows the company’s growing commitment to advancing hydrogen infrastructure, which is pivotal for the broad implementation of hydrogen fuel cell technology in the transportation sector.

The strategic location of the fuel station in Ontario at 401 West Mall aims to serve both local and regional fleets. It will address the infrastructure gap that has historically hampered the adoption of hydrogen-powered vehicles. Nikola and ITD industries have combined their expertise to enhance the accessibility and viability of hydrogen fuel as well as to provide tangible solutions to the pressing need for sustainable transportation.

According to Nikola CEO Steve Girsky, the fuel station in Ontario aligns with broader industry trends that favor hydrogen as a clean alternative to conventional fossil fuels. Girsky added that collaborating with ITD Industries means that the fueling solutions provided will benefit the entire hydrogen ecosystem, not only trucks.

Notable figures such as Ontario premier, Doug Ford, and associate minister of Energy-Intensive Industries, Sam Oosterhoff, attended the station’s opening event. Business leaders representing Walmart Canada, Canadian Tire and Loblaws were also in attendance, signifying the event’s importance in advancing Ontario’s clean-energy initiatives.

So, what’s so great about hydrogen fuel cells? Well, these cells provide zero-emission transportation, a great solution to the environmental challenges associated with diesel and gasoline engines. By setting up refueling infrastructure, both these companies are not only supporting the deployment of hydrogen vehicles but are also setting a precedent for future expansions.

The Ontario station is equipped with cutting-edge technology, including a 700-bar, pressure-fill system designed to facilitate efficient and safe hydrogen refueling. It will host state-of-the-art systems that support various vehicle types, including both heavy-duty trucks and passenger vehicles, to really bring out the versatility of hydrogen fuel. This is critical because this technology could serve various transportation needs, from logistic freight to simple personal commuting.

Ford, who helped ITD owner Benny Di Franco in cutting the ribbon during the opening, had a lot to say about the event. Ford congratulated Nikola Corporation and ITD Industries for the construction of the fuel station. He added that the station is a major step toward collaborating with businesses, industry and various governments to develop dependable, cost effective and sustainable energy solutions to support the growth of the province.

About BillionDollarClub

BDC is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BillionDollarClub, text “Billion” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BillionDollarClub.com

BillionDollarClub
Los Angeles, CA
www.BillionDollarClub.com
310.299.1717 Office
[email protected]

BillionDollarClub is powered by IBN

Russia to Authorize Crypto for International Trade as Workaround to Sanctions

August 7, 2024 08:05:00

Russian legislators recently approved a measure permitting businesses to engage in transnational trade using cryptocurrencies. This move aims to bypass Western sanctions instituted after Russia invaded Ukraine.

The legislation, expected to be enacted in September, has the support of Elvira Nabiullina, the governor of Russia’s central bank, who stated that the very first crypto transactions under the new law would take place before the year’s end. Russia has experienced substantial delays in transnational payments with…

About CryptoCurrencyWire

To receive SMS alerts from CryptoCurrencyWire, text “CRYPTO” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CryptoCurrencyWire.com

CryptoCurrencyWire
New York, NY
www.CryptoCurrencyWire.com
212.994.9818 Office
[email protected]

CryptoCurrencyWire is powered by IBN

InMed Pharmaceuticals Inc. (NASDAQ: INM) Subsidiary BayMedica Releases Market Report for 2023 on “Minor Cannabinoids”

August 7, 2024 08:05:00

The report explores the growth, competition, and consumer trends, for lesser known cannabinoids
The report highlights a 5.4% revenue increase in the edible market for 2023, with total sales reaching $2.097 billion
As consumer preferences shift towards edibles for their therapeutic effects and consistent experiences, the industry product landscape is set to evolve

With the increasing acceptance of cannabis use in society, the popularity of edibles—products containing cannabinoids that can be consumed as food or drink—has surged. While many consumers are familiar with edibles containing THC (tetrahydrocannabinol), known for its euphoric effects, or CBD (cannabidiol), recognized for its therapeutic benefits, there is a growing interest in edibles infused with non-intoxicating minor cannabinoids. These lesser-known cannabinoids offer unique properties and potential health benefits, driving significant market growth.

BayMedica, a subsidiary of InMed Pharmaceuticals (NASDAQ: INM), specializes in rare cannabinoids, and has published a report on the expansion of the minor cannabinoid market in 2023. Link to a full copy of…

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://cnw.fm/INM

About CannabisNewsWire

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

Research Team Develops Self-Healing Device to Generate Clean Energy

August 7, 2024 08:05:00

A research team from the Daegu Gyeongbuk Institute of Science & Technology (DGIST) in South Korea has developed a novel clean-energy-generation technology with self-healing properties. Led by Lee Joo-hyuk, a professor in the department of energy science and engineering, the team designed the biodegradable green device to enhance current renewable energy-generation capabilities while minimizing the burgeoning green-energy industry’s impact on the environment.

The ionic polyurethane-based triboelectric generator uses ionic liquid to boost its power output significantly and has high electropositive, self healing and biodegradable properties. The new design’s properties make it a potentially feasible sustainable energy source for the next generation of wearable and soft electronic devices.

With the world collectively striving to eliminate fossil fuels from its energy mix through strategies such as electrification and adopting clean energy, the new technology could be instrumental in helping the globe achieve net carbon neutrality. The novel green-energy-generation technology is built on years of research into triboelectric generators that use friction to convert kinetic energy to electricity.

Since regular friction can cause major mechanical damage over time, the design had to have self-healing properties that would prevent it from ultimately breaking down due to friction-induced damage. Furthermore, using biodegradable, or ecofriendly, materials in the design’s construction would increase its value as a green-energy device and significantly minimize its environmental impact once it finally loses functionality and is disposed of.

The research team behind the design has built a polyurethane-based triboelectric generator capable of producing clean energy for next-generation electric devices in a sustainable manner. Such novel technologies will be key to the world cutting down fossil fuel use to zero and achieving carbon neutrality. The device’s high electropositive properties and self-heating functions come from the imidazolium ions utilized in its design while polycaprolactone (PCL)-based polyurethane grants it its biodegradable capabilities.

The research team analyzed the ionic polyurethane-based device’s power output in different conditions to test its performance and found that it had a nearly 90% self-healing efficiency and could generate an energy density of up to 436.8 mW/m2. Furthermore, the team noted that just 21% of the device’s initial mass remained after biodegrading for 300 days.

Lee says the team’s research efforts led to the development of an efficient material that has both biodegradation and self-healing properties without compromising its high energy output. The researcher said that the prototype would potentially serve as a sustainable power source for the next generation of wearable electric devices and noted that his team would focus on commercializing the technology in its follow-up studies.

Many companies, such as FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF), are also investing in different ways to make clean energy more widely available at an affordable cost. As these efforts get traction in different markets, fossil fuels are likely to see reduced demand in the years to come.

NOTE TO INVESTORS: The latest news and updates relating to FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) are available in the company’s newsroom at https://ibn.fm/NHHHF

About GreenEnergyStocks

To receive SMS alerts from GreenEnergyStocks, text “Green” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenEnergyStocks.com

Please see full terms of use and disclaimers on the GreenEnergyStocks website applicable to all content provided by GES, wherever published or re-published: https://www.greennrgstocks.com/Disclaimer

GreenEnergyStocks
Los Angeles, CA
www.GreenEnergyStocks.com
310.299.1717 Office
[email protected]

GreenEnergyStocks is powered by IBN

420 with CNW — CU Anschutz Researchers Studying Users’ Capacity to Drive Under Influence of Marijuana

August 6, 2024 15:25:00

Researchers at the CU Anschutz School of Public Health have embarked on a paid study focusing on marijuana users to examine impairment levels. Over the past two years, the research has involved more than 200 participants aged between 25 and 55 years. Depending on the amount of marijuana consumed, each study session can last anywhere from three to five hours.

Dr. Ashley Brooks-Russell, a lead researcher at the school, explained, “This study allows us to observe the changes people experience after…

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

TechMediaBreaks – SuperCom Ltd. (NASDAQ: SPCB) Tech, PureSecurity Suite Offers Tools to Address Growing Domestic Violence Concerns

August 6, 2024 13:25:17

SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, Internet of Things (“IoT”) and cybersecurity sectors, has noted that electronic monitoring (“EM”) technology is being utilized as a significant and accessible solution for preventing domestic violence. With that in mind, the company is interested in seeing the tools in its PureSecurity Suite used to protecting victims of domestic violence; the platform can help track offenders and enforce court-issued protective orders. According to a recent article, the quality of SuperCom’s technology as well as other related services has led to an additional $11 million in new contract revenue for the company during the past few months. “People have been trying to do electronic monitoring for over 30 years, but many of the times they ran into technological hurdles,” said SuperCom president and CEO Ordan Trabelsi in the article. “With every project, we’re able to be one step ahead of the curve.”

To view the full article, visit https://ibn.fm/xVOy8

About SuperCom Ltd.

SuperCom has been a global provider of traditional and digital identity solutions since 1988, providing advanced safety, identification, and security solutions to governments and organizations, both private and public. Through its proprietary e-government platforms and innovative solutions for traditional and biometrics enrollment, personalization, issuance and border-control services, SuperCom has inspired governments and national agencies to design and issue secure multi-ID documents and robust digital-identity solutions to its citizens and visitors. SuperCom offers a unique all-in-one, field-proven radio frequency identification (“RFID”) and mobile technology and product suite, accompanied by advanced complementary services for various industries including security and safety, community public safety, law enforcement, domestic violence prevention and electronic monitoring. For additional information about this company, please visit www.SuperCom.com

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
[email protected]

TechMediaWire is powered by IBN

InvestorNewsBreaks – Finovate Shares FinovateFall Agenda Highlights

August 6, 2024 13:05:13

Finovate, a research and events company focused on innovation in financial and banking technology, is hosting FinovateFall, a pioneering fintech conference focused on the digital future of financial institutions. The event is slated for Sept. 9–11, 2024, in New York City. According to the announcement, the three-day fintech conference is “by and for executives and thought leaders who are revolutionizing the financial services industry.”

The event agenda includes presentations from more than 120 renowned speakers and subject matter experts and more than 60-plus live product demonstrations from a range of fintech companies, including startups to established players. Speakers for the event include Ben Maxim, chief digital strategy and innovation officer, MSU Federal Credit Union; Christopher Hollins, head of solutions sales and delivery, Silicon Valley Bank; Eric McCabe, senior vice president and head of embedded finance, Citizens Bank; Akita Somani, SVP BNPL/POS lending, U.S. Bank; Mary Joseph, vice president of strategic investments and TTS, Citi; and many other well-respected industry leaders.

To register for this event, visit https://ibn.fm/E1jvQ

To view the full press release, visit https://ibn.fm/2d6aU

About Finovate

Finovate is a research and events firm focused on innovation in financial and banking technology. Its team runs the Finovate conference series and authors the popular Finovate blog. Finovate is the only conference series focused exclusively on showcasing the best and most innovative new financial and banking technologies. Finovate conferences consistently attract large, high-impact audiences of senior financial and banking executives, venture capitalists, press, industry analysts, bloggers, regulators and entrepreneurs. For more information about the company, visit www.Finovate.com.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) JustCBD Brand Launches New Calm, Sleep Gummies

August 6, 2024 12:17:13

Flora Growth (NASDAQ: FLGC), a consumer-packaged goods leader and pharmaceutical distributor, through its JustCBD brand, has unveiled two new products: JustCBD+ Calm Gaba & L-Theanine Mixed Berry Gummies and JustCBD+ Sleep Magnesium and Melatonin Raspberry Gummies. These new gummy products are formulated to support stress management, promote relaxation and enhance sleep quality. Specifically, the JustCBD+ Calm Gaba & L-Theanine Mixed Berry Gummies are renowned for their calming properties while the JustCBD+ Sleep Magnesium & Melatonin Raspberry Gummies are designed to promote a restful night’s sleep.

JustCBD offers high-quality CBD products made from organically sourced hemp grown in the United States. The brand includes a wide range of CBD items, including everything from gummies and oil to soothing creams and pet treats.

“We are thrilled to expand our product line with these innovative gummies,” said Flor Growth CEO Clifford Starke. “Our mission is to enhance the lives of our customers, and these new products are a testament to our commitment to providing high-quality, effective solutions.”

To view the full press release, visit https://ibn.fm/kznop

About Flora Growth Corp.

Flora Growth is a consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 different countries with 20,000-plus points of distribution around the world. For more information about the company, please visit www.FloraGrowth.com.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

MiningNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Schedules Conference Call to Discuss Q2 2024 Results

August 6, 2024 12:06:44

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, is announcing the date for its upcoming conference call and webcast. The call is slated to begin at 11 a.m. EDT on Aug. 8, 2024. During the call, management will discuss the company’s second-quarter 2024 financial results as well as project developments. The call will also include time for questions and answers, with those on the call able to ask questions directly over the phone. Those wanting to participate can dial (888) 210-3454 toll free in North American, then use conference ID number 3232920. An archived replay of the webcast will be available on the company’s website approximately two hours after the call ends.

To view the webcast, visit https://ibn.fm/UkDa3

To view the full press release, visit https://ibn.fm/PUzlZ

About McEwen Mining Inc.

McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. The company also owns a 48.3% interest in McEwen Copper, which is developing the large, advanced-stage Los Azules copper project in Argentina. The company’s objective is to improve the productivity and life of its assets with the goal of increasing the share price and providing investor yield. Rob McEwen, chair and chief owner, has a personal investment of $225 million in the companies. His annual salary is $1. To learn more about the company, visit www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at https://ibn.fm/MUX

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Submits New CNM-Au8 Biomarker, Clinical Efficacy Data to FDA

August 6, 2024 11:52:25

Clene (NASDAQ: CLNN), a late-stage biopharmaceutical company focused on protecting mitochondrial health and neuronal function to treat neurodegenerative diseases, and its wholly owned subsidiary Clene Nanomedicine Inc., have submitted new data to the U.S. Food and Drug Administration (“FDA”). The data is regarding CNM-Au8(R) biomarker and clinical efficacy information, including post hoc analyses from two phase 2 clinical trials of CNM-Au8 for the treatment of ALS; the trials were conducted independently.

According to the announcement, this new data is in addition to original data the company has discussed with FDA and is intended to guide the planned FDA Type C interaction; that interaction is expected to take place in the Q3 2024 and will include discussion about an accelerated approval regulatory pathway.

Clene Nanomedicine is a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurological diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”).

“The risk-benefit assessment evidence of CNM-Au8 is strong,” said Clene CEO and president Rob Etherington in the press release. “Our next step is discussing this new CNM-Au8 biomarker and efficacy data with the FDA, with the hope that ALS patients will benefit from this drug, sooner rather than later.”

To view the full article, visit https://ibn.fm/AVplw

About Clene Inc.

NOTE TO INVESTORS: The latest news and updates relating to CLNN are available in the company’s newsroom at https://ibn.fm/CLNN

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

BioMedNewsBreaks — Astiva Health Announces Launch of Investor Relations Website to Facilitate Transparent, Effective Communication

August 6, 2024 11:40:25

Astiva Health, a leader in innovative and culturally aware healthcare solutions, today announced the launch of its new Investor Relations website. The launch marks a significant step and milestone in the company’s journey towards becoming a public company. It emphasizes Astiva Health’s commitment to maintaining transparent and effective communication and building strong relationships with investors, stakeholders, and the broader financial community. The platform will offer easy access to detailed company overviews and strategic vision, financial reports and performance metrics, press releases and media coverage, corporate government practices, and upcoming events and presentations. “We are excited to launch our Investor Relations website, a crucial tool that will facilitate transparent communication with our current and prospective investors. As we move towards our goal of becoming a public company, this platform will serve as a central hub for all investment-related information and updates,” commented Dr. Tri T. Nguyen, Co-founder and CEO of Astiva Health.

To view the full press release, visit https://ibn.fm/EddPK

About Astiva Health

Astiva Health is a fast-growing MAPD health plan committed to redefining the standards of personalized and comprehensive healthcare. With a mission to elevate the well-being of individuals, Astiva Health specializes in innovative health plans tailored to meet the unique requirements of its members. The organization prioritizes a culturally responsive approach to healthcare, offering multilingual solutions for customer service, marketing materials and educational resources. Astiva Health’s dedication to serving the underserved population is not only fulfilling a critical societal need but also positioning the company to tap into a market segment with significant growth potential. By addressing the diverse healthcare needs of its members, Astiva Health aims to create lasting relationships and contribute to the overall well-being of the communities it serves. Astiva Health invites individuals to join its transformative healthcare experience, where personalized care and lasting well-being take center stage. For more information about Astiva Health and enrollment details, please visit https://astivahealth.com.

NOTE TO INVESTORS: The latest news and updates relating to Astiva are available in the company’s newsroom at https://ibn.fm/Astiva

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Schedules Release of Q2 2024 Financial Results, Earnings Conference Call

August 6, 2024 11:30:36

Longeveron (NASDAQ: LGVN), a clinical-stage, regenerative-medicine biotechnology company developing cellular therapies for rare, life-threatening and chronic aging-related conditions, is planning to release its second-quarter 2024 financial report after markets close on Aug. 14, 2024. The company also announced that it has scheduled a conference call and webcast on the same day to discuss the report and provide a company update; the call will begin at 4:30 p.m. ET. To access the call, dial 1.877-407-0789 and then use the conference ID 13747923. An archived replay of the webcast will be available on company website following the event.

To view the webcast, visit https://ibn.fm/E4IZ6

To view the full press release, visit https://ibn.fm/yIbxp

About Longeveron Inc.

Longeveron is a clinical-stage, biotechnology company developing regenerative medicines to address unmet medical needs. The company’s lead investigational product is Lomecel-B(TM), an allogeneic medicinal signaling cell (“MSC”) therapy product isolated from the bone marrow of young, healthy adult donors. Lomecel-B(TM) has multiple potential mechanisms of action encompassing provascular, proregenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas. Longeveron is currently pursuing three pipeline indications: hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty. Lomecel-B development programs have received five separate and distinct FDA designations: for the HLHS program – Orphan Drug designation, Fast Track designation and Rare Pediatric Disease designation; and for the Alzheimer’s disease program – Regenerative Medicine Advanced Therapy (“RMAT”) designation and Fast Track designation. To learn more about the company, visit www.Longeveron.com.

NOTE TO INVESTORS: The latest news and updates relating to LGVN are available in the company’s newsroom at https://ibn.fm/LGVN

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

TechMediaBreaks – Snap Inc. (NYSE: SNAP) Faces Downturn Despite Revenue Growth

August 6, 2024 11:12:04

Snap (NYSE: SNAP), the parent company of Snapchat, faced a significant downturn in its stock value during after-hours trading following its second-quarter earnings report for 2024. Despite a 16% year-over-year increase in total revenue, reaching $1.24 billion, the decline in the company’s stock reflects investor concerns about Snap’s future growth prospects, especially given the deceleration from the 21% growth recorded in the first quarter of 2024. The mixed financial results also highlighted a net loss of $249 million, which, despite being a 34% improvement from the previous year, still raises questions about the company’s profitability.

Snap’s user engagement metrics, however, paint a more positive picture. The Daily Active Users (DAUs) reached 432 million, marking a 9% year-over-year increase, and Monthly Active Users (MAU) exceeded 850 million during the quarter. Additionally, the platform reported over 11 million subscribers to its premium subscription service, Snapchat+. CEO Evan Spiegel’s focus on growing the user base and scaling the advertising platform is evident, with active advertisers more than doubling year-over-year. These figures suggest a strong and growing engagement with Snap’s platform, despite the financial challenges.

The forward guidance for the third quarter of 2024 was a primary concern for investors, with projected DAUs reaching 441 million, a modest 9% increase from Q2. However, the revenue guidance for the quarter, ranging from $1.33 billion to $1.37 billion, implies a year-over-year revenue growth of only 12% to 16%. This forecast fell short of analyst expectations and signaled a potential slowdown in Snap’s growth trajectory, contributing to the negative investor sentiment.

Snap’s strategic investments in augmented reality (AR) technology and new feature development aim to enhance user experience and engagement. However, the company faces significant competition from other social media giants like Facebook (owned by Meta Platforms) and TikTok. These competitors have vast user bases and advanced advertising capabilities, posing a challenge to Snap’s growth and market share.

Investors are now looking forward to Snap’s upcoming Partner Summit on September 17th for further updates on the company’s strategy and potential changes in direction. The market’s response to the Summit will be crucial for determining Snap’s future trajectory and its ability to regain investor confidence amidst stiff competition and financial challenges.

To view the company’s most recent earnings release, visit https://ibn.fm/y3X8Z

About Snap Inc.

Snap Inc. is a technology company. We believe the camera presents the greatest opportunity to improve the way people live and communicate. We contribute to human progress by empowering people to express themselves, live in the moment, learn about the world, and have fun together. For more information, visit the company’s website at www.Snap.com.

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
[email protected]

TechMediaWire is powered by IBN

InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Schedules Release of Q1 2025 Results, Conference Call

August 6, 2024 10:57:42

Vistagen (NASDAQ: VTGN), a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, is announcing that it will host a conference call and webcast on Tuesday, August 13, 2024, at 2 p.m. PT (5 p.m. ET). During the call and webcast, the company will report results for the first quarter of its fiscal year 2025 ended June 30, 2024 (“Q1 2025”). In addition, Vistagen will provide a corporate update. Interested participants should dial 1-877-407-9716 (U.S. toll-free) or 1-201-493-6779 (toll/international) and enter the conference ID 13748020. Alternatively, partners can listen to the audio webcast of the conference call.

To listen to the audio webcast, visit https://ibn.fm/iN7Tf

To view the full press release, visit https://ibn.fm/dY81l

About Vistagen Therapeutics Inc.

Vistagen is a late clinical-stage neuroscience-focused biopharmaceutical company dedicated to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on its pioneering approach and deep understanding of nose-to-brain neurocircuitry. Designed exclusively as nasal sprays administered at microgram level doses, Vistagen’s diversified pipeline of pherine product candidates rapidly activate chemosensory neurons in the nasal cavity to impact olfactory system and brain neurocircuitry. Favorable safety profiles have been observed in all clinical studies of Vistagen’s pherine product candidates completed to date. Vistagen’s neuroscience pipeline also includes an oral prodrug with the potential to modulate NMDA receptor activity in multiple neurological conditions, such as levodopa-induced dyskinesia associated with Parkinson’s disease therapy and neuropathic pain. Vistagen is passionate about creating novel and differentiated treatments that set new standards of care for millions of people living with anxiety, depression, and other neurological disorders. For more information, visit the company’s website at www.Vistagen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

CryptoNewsBreaks – Blockchain Futurist Conference Plays Pivotal Role in Shaping the Future of Web3, Finance

August 6, 2024 10:48:33

Blockchain Futurist Conference is Canada’s largest and most high-profile Web3, blockchain and cryptocurrency event. Serving as an essential platform for ideas and collaboration, the conference has proven to be an important global gathering helping shape the future of Web3. This year’s event is scheduled for August 13-14, 2024, in Toronto, Canada; the event will run alongside ETHToronto and ETHWomen Hackathons, the largest web3 hackathons in Canada. During Futurist 2023, reporter Daniel Bruno solicited quotes from onsite attendees experiencing the excitement of the event. What they said sets the tone for this year’s dynamic must-attend Blockchain Futurist Conference. “We have attended as a sponsor since the inception, and we can see the momentum growing. We think this is the best and only event in Canada that gives everyone an opportunity to learn about crypto and Web3,” said Peter I of VirgoCX.

To view the full article, visit https://ccw.fm/8TwdR

About Blockchain Futurist Conference

Untraceable’s Blockchain Futurist Conference is Canada’s largest and most high-profile blockchain and cryptocurrency event. Like no other conference, this annual event is tailored to foster engagement from its participants with hands on technology weaved into every aspect of the conference. The event brings together a global audience of attendees, including startups, investors, developers, enterprise leaders, financial institutions, researchers, academics, and emerging tech pioneers, to build the future. Attendees can expect to hear leading experts discuss trends, showcase the newest tech and debate topics that are sure to shape this technological revolution. For more information about the event, please visit www.FuturistConference.com.

About CryptoCurrencyWire

To receive SMS alerts from CryptoCurrencyWire, text “CRYPTO” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CryptoCurrencyWire.com

CryptoCurrencyWire
New York, NY
www.CryptoCurrencyWire.com
212.994.9818 Office
[email protected]

CryptoCurrencyWire is powered by IBN

BioMedNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Reports on Clinical Data Showing Lead Compound Combined with GLP-1 Agonist Enhances Cognition

August 6, 2024 10:16:54

Annovis Bio (NYSE: ANVS), a late-stage, clinical-drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), is reporting preclinical data regarding its lead compound, buntanetap. According to the announcement, the results show the synergistic effect of buntanetap when combined with the glucagon-like peptide 1 (“GLP-1”) agonist dulaglutide (Trulicity[R]) in a mouse model of Alzheimer’s disease.

Based on data gathered in 2018 showing that buntanetap fully restored memory, learning and synaptic potentiation in an Alzheimer’s mouse model, Annovis recently studied whether buntanetap combined with the GLP-1 agonist dulaglutide produced a synergistic effect in the same animal model. Calling the results “compelling,” the company reported that while buntanetap alone restored cognitive function to 100%, the two compounds together enhanced cognitive function beyond levels seen in healthy controls.

“We are excited to see that buntanetap significantly amplifies the effects of dulaglutide on memory and learning, with a 6- to 10-fold increase in efficacy,” said Annovis Bio founder, president and CEO Maria Maccecchini, PhD, in the press release. “This synergy is particularly important for enhancing treatment outcomes while minimizing potential side effects. As the field of Alzheimer’s research shifts towards combination therapies, we believe our approach holds great promise for offering more effective treatment options for patients.”

To view the full press release, visit https://ibn.fm/mq0de

About Annovis Bio Inc.

NOTE TO INVESTORS: The latest news and updates relating to ANVS are available in the company’s newsroom at https://ibn.fm/ANVS

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

TinyGemsBreaks – Nightfood Holdings Inc. (NGTF) Expands into Growing Food-Service Segment with Recent Acquisition

August 6, 2024 10:14:49

Nightfood Holdings (OTCQB: NGTF), a forward-thinking acquisition and development holding company, has built a reputation in the sleep-friendly snack market. Now the company is expanding beyond the nighttime snack category into a growing segment of the food-service industry through recent acquisitions designed to diversify operations and capitalize on an emerging market.

According to the article, Nightfood signed a letter of intent (“LOI “) to acquire SWC Group Inc., doing business as Carryoutsupplies.com, or CarryOut for short. CarryOut specializes in custom-printed food packaging and offers traditional and environmentally friendly selections for restaurants, cafes and other food-service businesses.

“We are thrilled at the opportunity to acquire rapidly growing CarryOut Supplies and for the opportunity to restore it to its pre-COVID scale and beyond,” said Nightfood CEO Sonny Wang in the article. “CarryOut is an exciting standalone business, and the strategic value of this acquisition is greatly enhanced by synergies with our existing subsidiaries and those we anticipate acquiring in the future.”

To view the full article, visit https://ibn.fm/PvH8b

About Nightfood Holdings Inc.

Nightfood is a forward-thinking holding company dedicated to identifying and capitalizing on explosive market trends within the hospitality, food services, consumer packaged goods and commercial real estate sectors. The company’s mission is to create unparalleled upside potential in industries ripe for innovation and growth by leading newly emerging categories and seizing opportunities in markets undergoing transformational upheaval. Nightfood is at the forefront of introducing and deploying artificial intelligence-enabled robotics products, revolutionizing operational efficiencies and customer experiences across the company’s focus areas. Additionally, the company is committed to developing and marketing wellness-focused consumer packaged goods, meeting the growing demand for healthier and functional options. Through these strategic initiatives, Nightfood endeavors to drive significant value and growth for its stakeholders. For more information about the company, visit the company’s website at www.NightFood.com.

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at https://ibn.fm/NGTF

About TinyGems

To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems
Los Angeles, CA
www.TinyGems.com
310.299.1717 Office
[email protected]

TinyGems is powered by IBN

Company Receives First Psilocybin Edible Manufacturing License from Oregon Authorities

August 6, 2024 10:05:00

Oregon regulators have issued the state’s first-ever psychedelic edibles manufacturer license to Spiritus Oregon, a Milwaukie-based company that manufactures psilocybin edibles. The company offers its edibles under the Horizon Edibles brand, noting in a press release that its dark chocolate edibles were dosed with homogenized, dried mushrooms. This, they stated, had a nutty, earthy flavor.

According to its site, Spiritus provides white-label products and manufactures its own psilocybin edibles. It is also licensed as a…

About PsychedelicNewsWire

To receive SMS alerts from PsychedelicNewsWire, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.PsychedelicNewsWire.com

PsychedelicNewsWire
San Francisco, CA
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]

PsychedelicNewsWire is powered by IBN

Blackbird Labs Creates Web3 Platform to Help Restaurants Receive Payments

August 6, 2024 10:05:00

Blackbird Labs, a hospitality technology startup established by Ben Leventhal, has launched an innovative Web3 payments platform known as Blackbird Pay. This crypto app designed specifically for restaurant industry players leverages the power of blockchain technology to revolutionize how restaurants manage payments and settle checks.

Blackbird Labs’ platform comes at a time when many restaurants are struggling with rising costs and shrinking margins post-COVID. According to a…

About Web3MediaWire

To receive SMS alerts from Web3MediaWire, text “Web3” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.Web3MediaWire.com

Please see full terms of use and disclaimers on the Web3MediaWire website applicable to all content provided by W3MW, wherever published or re-published: https://www.Web3MediaWire.com/Disclaimer

Web3MediaWire
Los Angeles, CA
www.Web3MediaWire.com
310.299.1717 Office
[email protected]

Web3MediaWire is powered by IBN

Tinder to Lay Off 6% of Staff Despite Q2 Revenue Growth

August 6, 2024 10:05:00

Tinder’s parent company Match Group is set to terminate 6% of its workforce as part of its efforts to eliminate live-streaming services from its dating platforms. Although Tinder’s revenue report for Q2 2024 revealed that the dating app had seen 4% growth through the quarter and earned around $864 million in revenue, its parent company has decided to eliminate a sizeable portion of its workforce.

The decision comes amid an industry-wide slump characterized by slow user growth that began during the coronavirus pandemic and has…

About ChineseWire

For more information, please visit https://www.ChineseWire.com

Please see full terms of use and disclaimers on the ChineseWire website applicable to all content provided by CW, wherever published or re-published: https://www.ChineseWire.com/Disclaimer

ChineseWire
Los Angeles, CA
www.ChineseWire.com
310.299.1717 Office
[email protected]

ChineseWire is powered by IBN

GreenCarNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Shares Update from CEO

August 6, 2024 09:26:05

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today provided an update from CEO and chairman David Michery. According to the update, the company believes it has a strong foundation for future growth in EV sales based on the value of its total assets and cash position. Mullen highlighted the $250 million in new financing commitments it has secured to accelerate its growth plan, the expansion of its sales and distribution reach, the receipt of new orders, the delivery of vehicles, and negotiations to expand its customer base and market share. In addition, Mullen noted that it is developing technologies, such as solid-state polymer packs, to drive future growth.

“Despite challenging economic headwinds where many enterprises are capital-constrained, our balance sheet remains strong, and we have achieved meaningful accomplishments since our last update to shareholders in June 2024,” the update reads. “These achievements are a testament to the hard work and dedication of our team, and we are excited about the opportunities ahead. We remain focused on delivering value to our shareholders through innovation, operational excellence and strategic partnerships.”

To view the full press release, visit https://ibn.fm/PNmeV

About Mullen Automotive Inc.

NOTE TO INVESTORS: The latest news and updates relating to MULN are available in the company’s newsroom at https://ibn.fm/MULN

About GreenCarStocks

To receive SMS alerts from GreenCarStocks, text “Green” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the GreenCarStocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

GreenCarStocks
Los Angeles, CA
www.GreenCarStocks.com
310.299.1717 Office
[email protected]

GreenCarStocks is powered by IBN

InvestorNewsBreaks – Ocugen Inc. (NASDAQ: OCGN) Closes on $35M Public Offering

August 6, 2024 09:13:50

Ocugen (NASDAQ: OCGN), a biotechnology company focused on discovering, developing and commercializing novel gene and cell therapies and vaccines, has closed on its previously announced underwritten public offering. The offering was comprised of 30,434,783 shares of its common stock, with each share sold at $1.15 per share. The company is anticipated to receive an estimated $35 million in gross proceeds, before standard deductions and expenses are made. Ocugen plans to use the funds from the offering for general corporate purposes, capital expenditures, working capital, and general and administrative expenses. Titan Partners Group, a division of American Capital Partners, acted as sole book-running manager for the offering.

To view the full press release, visit https://ibn.fm/XgLie

About Ocugen Inc.

Ocugen is a biotechnology company focused on discovering, developing and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company is making an impact on patient’s lives through courageous innovation, forging new scientific paths that harness its unique intellectual and human capital. Ocugen’s breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with a single product, and the company is advancing research in infectious diseases to support public health and orthopedic diseases to address unmet medical needs.

To learn more about the company, visit www.Ocugen.com.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Clene Inc. (NASDAQ: CLNN) Advances Neurodegenerative Disease Treatment with Innovative Nanotherapeutics

August 6, 2024 08:50:00

Clene is developing a new class of drugs that hold the potential to transform the lives of millions suffering from debilitating conditions such as Amyotrophic Lateral Sclerosis (“ALS”), Multiple Sclerosis (“MS”), and Parkinson’s Disease (“PD”)
CNM-Au8(R), Clene’s lead drug candidate, is a fundamentally new approach for treating the underlying factors contributing to ALS, MS, and PD, by restoring neuronal health and function
ALS, the most prevalent adult-onset progressive motor neuron disease, affects approximately 30,000 people in the U.S.

Clene (NASDAQ: CLNN), a pioneering biopharmaceutical company, is making significant strides in the treatment of neurodegenerative diseases through its novel nanotherapeutic platform. With a mission to improve underlying mitochondrial health and protect neuronal function, Clene is developing a new class of drugs that hold the potential to transform the lives of millions suffering from debilitating conditions such as Amyotrophic Lateral Sclerosis (“ALS”), Multiple Sclerosis (“MS”), and Parkinson’s Disease (“PD”).

At the forefront of Clene’s innovations is CNM-Au8, a gold nanocrystal suspension currently in development. CNM-Au8 is designed to act as a treatment for ALS, MS, and PD by restoring neuronal health and function. The drug works by increasing cell energy production and…

NOTE TO INVESTORS: The latest news and updates relating to CLNN are available in the company’s newsroom at https://ibn.fm/CLNN

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

Nightfood Holdings Inc. (NGTF): Capitalizing on the Booming Late-Night Snack Market